rfhg_109251.1

Basic information about the TSS

---

TSS ID: rfhg_109251.1 Species: human Chr: chr8		Start: 100712386 End: 100712458 Strand: -
Source datasets	PRJNA401781
Protocol	oligo_capping
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000523636.5:0 GeneID: 26986 HGNC/MGI_ID: HGNC:8554 UniProt_ID: H0YB86 Nearer transcript ids and distances: ENST00000517403.5:-303

Gene_name: poly(A) binding protein cytoplasmic 1 Gene_symbol: PABPC1 Gene_synonyms: PABP1 PABPL1 Gene_source: HGNC:8554

TATA-Box annotation

---

Distance to TSS:	-9398
Nearest PromoterID:	NR_106992
Entrez ID:	102466854
Nearest Unigene:
Nearest Refseq:	NR_106992
Nearest Ensembl:	ENSG00000284570
Gene Name:	poly(A) binding protein cytoplasmic 1
Gene Alias:	hsa-mir-7705
Gene Type:	ncRNA
CpG%:	0.027778
GC%:	0.369863
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PABPC1 p2@PABPC1 p3@PABPC1 p4@PABPC1 p5@PABPC1 p6@PABPC1 p7@PABPC1 p8@PABPC1 p10@PABPC1
Sample		p1@PABPC1	p2@PABPC1	p3@PABPC1	p4@PABPC1	p5@PABPC1	p6@PABPC1	p7@PABPC1	p8@PABPC1	p10@PABPC1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	412.59	5.65	1.56	1.17	2.14	0.00	1.17	1.95	2.92
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	363.36	3.44	0.61	0.61	2.23	0.81	3.44	1.21	4.25
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	377.90	2.51	2.12	0.96	3.28	0.39	1.35	1.74	2.51
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	387.13	2.70	2.08	0.83	1.04	0.42	1.66	2.08	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	365.57	3.15	1.57	0.45	1.12	0.90	0.90	1.57	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	332.58	2.71	1.74	1.36	1.55	0.00	2.33	0.97	2.52
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	408.10	3.49	3.70	0.65	2.61	0.87	2.40	1.09	4.14
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	367.45	4.36	1.45	0.73	1.21	0.97	2.42	0.97	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	344.73	2.56	1.71	1.07	0.85	0.43	1.71	0.85	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	339.08	4.06	1.16	1.16	1.16	1.74	4.06	1.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	289.03	1.62	2.83	1.62	2.43	1.21	2.83	0.81	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	326.87	4.07	2.85	1.22	2.44	0.00	2.85	1.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	848.20	12.41	7.41	4.35	3.87	0.32	0.81	4.84	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	781.82	13.68	7.37	5.41	2.56	0.15	0.00	5.56	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	789.51	13.39	6.81	3.29	6.81	0.00	0.44	4.83	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	883.49	9.31	10.81	4.78	5.03	0.00	0.50	5.53	2.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	797.19	9.39	6.33	4.15	3.71	0.22	0.44	8.30	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	779.94	10.55	11.81	5.06	6.33	0.00	0.42	7.17	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	642.98	11.20	6.40	4.80	5.33	0.00	0.00	3.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	777.93	13.24	7.97	3.31	5.12	0.30	1.05	5.12	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	782.53	12.16	6.68	3.74	4.95	0.40	0.53	6.28	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	863.98	10.01	3.80	3.11	3.11	0.17	0.17	5.01	1.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	812.12	11.89	7.37	4.39	4.14	0.26	0.65	5.04	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	755.91	9.95	5.34	3.15	4.37	0.73	0.00	7.77	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	797.96	11.87	7.74	3.35	4.13	0.26	0.77	4.39	3.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	693.79	11.08	5.70	2.85	6.65	0.63	0.32	7.28	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	800.56	7.69	6.04	2.20	4.95	0.55	0.55	6.59	2.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	643.37	15.32	5.66	3.54	4.24	0.24	0.47	3.54	6.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	795.83	12.44	5.33	3.55	3.88	0.00	0.48	5.98	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	756.80	8.51	5.43	3.26	3.98	0.18	0.18	3.98	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	730.19	10.26	6.28	2.93	6.28	0.00	0.21	6.28	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	792.66	9.38	8.21	3.13	5.86	0.20	0.00	2.54	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	796.64	8.86	8.65	2.11	6.12	0.42	0.63	6.12	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	715.84	10.72	8.08	2.80	7.26	0.16	0.00	1.81	3.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	735.24	12.15	8.79	4.30	5.42	0.19	0.00	5.05	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	698.08	14.75	5.94	3.07	4.41	0.00	0.57	4.02	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	755.80	9.20	7.77	1.84	6.34	0.00	0.20	4.91	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	699.97	11.89	6.25	3.43	4.23	0.20	0.00	3.63	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	663.37	9.72	6.48	3.78	7.56	0.00	0.54	2.43	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	606.88	8.40	6.72	3.12	5.76	0.24	0.00	4.80	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	642.49	11.29	6.35	2.35	3.29	0.00	0.47	3.53	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	550.30	11.13	7.76	2.64	5.42	0.44	0.15	2.20	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	649.55	13.71	8.65	4.64	3.16	0.42	0.63	3.37	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	815.22	10.31	8.57	5.59	3.15	0.35	0.17	3.50	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	779.80	12.45	7.23	4.62	3.81	0.00	0.80	1.81	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	765.64	14.19	10.93	4.65	9.07	0.00	0.00	9.77	4.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	743.95	12.00	8.40	3.60	3.84	0.00	0.24	5.52	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	692.37	10.43	5.36	3.58	3.58	0.00	0.00	3.28	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	706.15	9.34	10.05	2.87	3.59	0.24	0.24	5.27	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	746.11	13.55	6.47	4.45	3.84	0.20	0.20	3.64	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	706.27	13.12	6.76	1.64	4.51	0.00	0.00	5.53	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	701.59	12.68	5.34	2.67	6.45	0.22	0.22	5.11	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	3092.27	69.96	13.99	13.99	41.98	0.00	0.00	13.99	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	865.85	5.32	3.55	3.55	4.97	0.00	1.06	3.90	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	684.97	5.63	4.97	3.65	3.31	0.33	0.00	2.98	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	300.34	26.85	9.23	4.19	16.78	0.00	0.00	3.36	14.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	262.23	12.40	5.05	0.46	7.81	0.00	0.46	0.92	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	525.70	5.83	3.89	5.19	1.94	0.00	0.65	1.62	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	616.32	5.14	4.18	1.61	3.53	0.00	0.00	1.93	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	297.04	9.43	8.49	1.26	3.46	0.00	0.00	1.89	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	769.21	4.23	1.41	1.41	2.12	0.00	0.00	1.41	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	663.97	1.68	2.80	1.68	4.49	0.00	0.00	2.80	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	220.53	21.50	18.31	5.57	7.96	0.00	0.00	3.18	11.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	235.12	9.17	4.76	1.36	3.06	0.00	0.34	2.72	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	720.02	6.82	7.15	3.25	1.30	0.00	0.00	2.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	526.43	2.84	3.90	1.42	2.84	0.00	0.35	3.19	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	2602.39	32.33	0.00	0.00	0.00	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1690.06	0.00	15.79	7.90	23.69	0.00	7.90	0.00	31.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	476.30	1.95	2.44	0.49	2.44	0.00	0.00	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	425.46	4.46	0.99	0.99	1.49	0.00	0.50	1.49	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	204.53	3.75	1.41	0.94	1.88	0.00	0.47	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	185.13	3.31	2.65	0.00	2.65	0.00	0.33	1.32	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	529.28	3.71	2.78	2.78	1.86	0.31	0.00	2.17	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	496.53	3.06	1.53	0.61	0.92	0.31	0.31	2.45	0.92
Adipocyte - breast, donor1	11376-118A8	463.27	4.59	7.60	2.69	0.95	0.00	0.00	0.48	0.00
Adipocyte - breast, donor2	11327-117E4	314.28	4.49	5.78	1.12	0.96	0.00	0.00	1.93	0.16
Adipocyte - omental, donor1	11473-119C6	580.41	5.85	9.03	2.80	1.15	0.25	0.13	0.51	0.13
Adipocyte - omental, donor2	11474-119C7	289.28	2.24	1.49	0.75	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	421.33	3.35	4.35	2.01	0.00	0.00	0.00	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	359.83	0.00	2.55	1.28	0.00	0.00	0.00	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	221.00	2.20	3.30	2.20	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	539.24	9.48	14.00	3.16	2.71	0.00	0.45	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	640.36	9.21	13.21	7.12	1.04	0.17	0.00	2.61	4.34
Adipocyte differentiation, day04, donor1	13019-139D4	701.52	6.26	6.26	6.06	0.20	0.20	0.39	1.76	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	397.14	2.83	2.32	1.03	0.26	0.26	0.51	1.03	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	446.59	4.18	2.79	3.07	0.84	0.00	0.00	1.67	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	449.09	3.53	4.70	1.18	0.59	0.00	0.00	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	564.64	6.11	6.84	2.90	0.40	0.24	0.24	0.88	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	390.21	1.61	1.29	2.58	0.65	0.00	0.32	2.26	1.94
Adipocyte differentiation, day08, donor3	13026-139E2	311.38	5.33	4.80	2.67	1.07	0.00	0.00	1.60	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	344.99	3.90	1.11	2.23	1.11	0.00	0.56	2.23	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	271.99	2.50	0.83	2.50	0.00	0.00	0.00	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	301.40	3.27	1.00	1.76	0.50	0.00	0.00	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	257.21	2.29	1.96	0.65	1.64	0.33	0.33	2.95	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	204.00	0.91	1.52	0.91	0.00	0.30	0.00	0.91	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	449.73	2.65	0.88	0.22	1.33	0.22	0.22	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	208.69	0.72	0.36	0.36	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	276.74	1.20	1.20	1.20	1.20	0.00	0.00	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	828.47	3.78	2.16	0.36	1.08	0.18	0.00	0.54	1.08
Amniotic Epithelial Cells, donor2	11613-122A2	565.64	3.35	1.67	0.00	1.67	0.00	0.00	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	779.67	5.55	4.52	2.26	1.85	0.41	0.21	1.23	1.64
Anulus Pulposus Cell, donor1	11248-116E6	666.53	2.52	2.17	1.14	1.03	0.11	0.00	0.69	3.20
Anulus Pulposus Cell, donor2	11463-119B5	478.06	2.69	2.45	0.98	0.73	0.00	0.24	0.24	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	373.36	1.80	0.45	0.45	1.35	0.45	0.00	0.45	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	376.83	1.74	2.17	1.30	0.87	0.00	0.00	2.60	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	222.59	4.28	0.00	0.00	4.28	0.00	0.00	4.28	6.42
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	365.28	1.79	0.60	0.30	0.00	0.00	0.00	1.20	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	553.92	3.79	1.26	0.00	1.26	0.00	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	175.58	3.30	0.00	1.32	1.32	0.00	0.00	0.66	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	301.82	0.65	1.30	0.32	1.62	0.00	0.00	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	320.88	2.43	0.49	0.49	0.97	0.00	0.00	0.49	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	242.90	0.59	0.59	0.59	1.78	0.00	0.00	1.19	2.97
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	403.00	2.26	0.75	0.38	1.13	0.00	0.00	1.13	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	310.59	1.45	0.00	1.45	0.00	0.00	0.73	0.00	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	169.26	1.25	1.25	0.00	2.51	0.00	0.00	3.76	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	452.37	3.13	0.66	0.33	0.33	0.16	0.00	0.49	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	324.82	1.36	0.00	0.00	1.36	0.00	0.00	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	225.43	0.90	1.36	0.60	0.75	0.30	0.30	0.30	1.36
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	308.61	3.21	0.00	0.00	0.54	0.00	0.00	1.07	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	339.33	1.89	0.76	0.76	0.57	0.00	0.19	0.76	2.27
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	329.56	2.94	1.34	0.53	0.00	0.27	0.00	0.00	2.41
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	274.10	0.98	0.98	0.00	0.98	0.00	0.00	0.00	2.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	347.64	1.99	0.66	0.66	0.66	0.00	0.00	0.50	2.82
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	164.50	0.00	0.00	0.00	2.40	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	403.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	369.65	1.72	0.00	0.51	1.37	0.00	0.00	0.51	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	146.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	357.76	2.43	0.49	0.00	0.49	0.00	0.00	1.46	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	349.85	2.28	0.00	0.00	0.00	0.00	0.00	2.28	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	199.88	2.42	3.63	0.00	4.85	0.00	0.00	2.42	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	334.04	0.00	1.14	0.57	0.57	0.00	0.00	0.00	2.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	339.05	1.50	0.64	0.43	0.64	0.21	0.00	1.28	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	249.31	2.06	0.52	0.00	0.52	0.00	0.00	1.03	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	337.36	1.41	0.00	0.00	0.00	0.47	0.47	0.94	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	327.66	2.89	0.64	0.96	1.29	0.00	0.32	1.61	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	176.94	3.57	0.71	0.71	0.71	0.00	0.00	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	262.64	1.17	0.58	0.00	0.58	0.00	0.00	0.00	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	399.52	1.81	0.30	1.20	0.90	0.00	0.00	0.60	2.11
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	235.22	1.19	1.19	0.00	0.00	0.00	1.19	1.19	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	338.19	3.56	0.00	0.51	1.53	0.00	0.00	0.51	3.05
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	336.19	1.53	1.27	0.51	1.53	0.00	0.25	1.27	3.31
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	189.34	0.64	0.64	1.27	1.27	0.00	0.00	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	299.05	1.73	0.00	0.00	0.86	0.00	0.00	0.43	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	355.00	1.48	0.21	0.21	0.42	0.00	0.00	0.64	1.69
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	227.93	0.58	0.29	0.87	0.58	0.00	0.00	0.87	2.61
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	372.23	0.94	0.00	0.00	0.00	0.00	0.00	0.94	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	334.64	1.70	0.51	0.00	0.34	0.17	0.00	0.85	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	224.69	2.32	0.00	0.00	0.00	0.00	0.00	2.32	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	382.38	0.00	0.00	0.00	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	345.20	1.93	0.43	0.43	1.29	0.00	0.00	0.00	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	226.23	0.00	1.20	0.00	1.20	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	349.18	0.73	0.73	0.00	0.73	0.00	0.00	0.73	2.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	343.21	2.53	1.15	0.69	1.38	0.23	0.00	1.15	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	255.03	2.55	5.10	5.10	2.55	0.00	0.00	7.65	22.95
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	246.86	0.25	0.51	0.51	0.25	0.00	0.00	0.51	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	367.26	1.45	0.62	0.62	0.21	0.00	0.00	0.62	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	253.37	0.92	0.31	0.31	1.22	0.00	0.00	0.61	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	426.86	1.91	0.96	0.48	0.00	0.00	0.00	1.91	2.39
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	369.86	1.33	1.33	0.44	1.11	0.00	0.00	0.89	2.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	184.62	0.00	1.53	0.00	1.53	0.00	0.00	1.53	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	273.07	0.55	1.11	0.00	0.00	0.55	0.00	0.55	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	372.04	1.59	1.32	0.26	0.53	0.00	0.00	1.85	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	222.07	1.82	0.73	1.09	0.36	0.00	0.00	1.45	1.09
Astrocyte - cerebellum, donor1	11500-119F6	990.76	2.82	1.23	0.37	0.61	0.98	0.25	0.25	0.12
Astrocyte - cerebellum, donor2	11580-120F5	607.45	2.57	1.71	0.34	0.17	0.34	0.17	0.51	0.68
Astrocyte - cerebellum, donor3	11661-122F5	574.50	2.94	1.47	1.05	0.42	0.84	0.21	1.05	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	617.34	1.74	1.05	0.70	1.39	0.35	0.00	0.35	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	548.57	3.07	0.65	0.81	2.10	0.65	0.00	1.29	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	451.51	2.68	1.94	1.19	0.89	0.89	0.30	1.04	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	2266.76	13.53	9.29	6.08	1.83	1.03	1.26	2.06	3.78
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	2469.43	13.28	6.39	4.89	1.88	1.25	1.25	2.63	1.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	2388.02	11.38	6.26	5.12	2.50	1.59	0.68	2.50	1.93
Basophils, donor1	12241-129G9	467.10	6.54	2.88	1.31	0.78	0.26	0.00	0.26	0.26
Basophils, donor2	12242-129H1	719.43	6.86	3.97	2.89	2.16	0.00	0.00	0.72	1.08
Basophils, donor3	12243-129H2	1728.25	8.23	5.73	3.97	1.76	0.59	1.03	1.62	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	782.42	3.67	1.72	0.86	3.45	0.00	0.00	0.86	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	245.05	0.91	1.37	0.46	0.00	0.00	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	573.89	0.00	7.17	7.17	0.00	0.00	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	207.13	0.00	1.26	0.00	0.00	0.63	1.26	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	340.21	1.25	1.66	0.83	0.83	0.00	0.21	0.21	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	630.54	6.45	5.07	3.45	2.07	0.69	0.23	0.69	2.30
Bronchial Epithelial Cell, donor7	11769-123I5	646.00	4.14	0.90	0.54	2.34	0.00	0.00	1.08	4.32
Burkitt's lymphoma cell line:DAUDI	10422-106C8	3819.54	13.29	4.95	2.37	3.50	0.31	1.24	3.81	1.65
Burkitt's lymphoma cell line:RAJI	10476-106I8	3959.13	9.78	4.89	3.49	4.89	0.93	2.10	2.33	3.26
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	681.76	2.56	1.60	0.64	0.00	0.64	0.96	1.28	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	341.28	0.00	0.00	10.34	0.00	0.00	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	870.13	23.67	2.25	1.69	0.56	0.56	0.56	2.25	0.00
CD14+ Monocytes, donor2	11305-117B9	1605.45	24.31	7.61	2.04	3.34	0.19	0.19	1.30	2.23
CD14+ Monocytes, donor3	11381-118B4	1092.41	19.76	4.83	4.61	1.54	0.22	0.66	3.29	4.39
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	908.57	11.04	19.53	9.34	2.55	0.00	0.00	1.98	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	974.60	13.65	17.44	6.82	1.14	1.14	0.00	1.14	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	1213.71	11.83	23.34	10.85	0.99	0.33	0.00	3.29	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	1319.59	16.91	9.83	5.78	1.16	0.72	0.14	3.61	1.88
CD14+ monocytes - mock treated, donor2	11873-125C1	1422.72	18.10	9.96	5.73	2.11	0.60	0.00	4.83	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	1307.89	14.21	7.82	4.03	2.84	0.71	0.24	1.18	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1121.06	10.71	7.37	3.52	3.18	0.33	0.17	2.51	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1317.68	11.87	5.24	1.66	2.76	0.55	0.00	1.66	1.38
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	1100.56	9.92	4.21	2.73	1.24	0.25	0.25	2.23	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	1074.55	7.24	4.90	2.35	2.15	0.98	0.00	1.17	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	1187.94	11.04	4.81	1.07	3.92	0.00	0.00	1.96	1.60
CD14+ monocytes - treated with BCG, donor3	11880-125C8	847.23	9.14	3.48	1.52	2.83	0.22	0.00	1.96	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1190.07	28.33	7.49	2.34	3.04	0.94	0.23	1.87	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1704.47	18.48	7.39	3.70	4.22	0.53	0.00	2.11	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1258.01	24.41	6.66	1.11	2.22	0.00	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1228.96	11.60	10.26	6.84	3.72	0.45	0.00	3.27	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1347.35	12.37	8.18	6.19	3.79	0.20	0.00	2.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	845.08	7.70	7.91	2.91	1.87	0.21	0.00	1.04	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	1431.05	32.95	11.44	8.01	2.97	0.69	0.00	4.35	2.75
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1221.50	30.31	10.18	6.11	1.13	0.00	0.00	2.49	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1268.79	43.65	17.89	6.55	2.18	0.87	0.00	1.75	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1141.05	9.68	6.99	3.23	1.88	0.54	0.00	3.23	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1545.54	17.97	9.25	5.23	2.97	1.40	0.52	2.62	1.74
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	1421.95	16.41	4.63	2.95	2.95	0.00	0.42	2.10	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1124.49	25.17	6.98	2.20	2.76	0.18	0.18	2.20	2.20
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1272.38	33.11	7.75	1.41	2.82	0.35	0.35	3.17	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1352.15	40.80	10.97	1.75	3.95	0.88	0.00	0.88	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1177.55	9.94	4.36	1.57	2.96	0.70	0.00	3.31	2.62
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	1337.29	13.01	3.72	2.60	4.83	0.00	0.37	3.35	1.86
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1221.09	10.78	6.47	1.08	5.60	0.00	0.22	2.16	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1040.51	24.98	4.91	3.28	2.05	0.41	0.00	2.46	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	896.13	36.86	7.19	1.16	3.25	0.23	0.00	1.16	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	875.07	40.83	5.57	2.32	3.25	0.70	0.00	0.23	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	686.15	5.67	3.92	1.31	1.96	0.00	0.22	1.74	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	1274.40	8.55	6.47	2.08	3.00	0.23	0.46	1.15	3.23
CD14+CD16+ Monocytes, donor3	11912-125G4	507.75	2.38	2.38	0.43	1.95	0.22	0.65	0.65	1.30
CD14+CD16- Monocytes, donor1	11788-124B6	1496.80	9.50	4.98	1.56	2.80	0.31	0.47	1.09	2.80
CD14+CD16- Monocytes, donor2	11799-124C8	1425.27	5.76	6.64	1.75	2.62	0.17	0.00	1.57	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	1561.23	10.70	9.14	2.68	1.34	1.34	0.45	1.78	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	495.29	2.55	1.79	0.77	0.51	0.26	0.51	0.51	4.08
CD14-CD16+ Monocytes, donor2	11800-124C9	1051.28	8.56	3.95	2.63	1.76	0.00	0.44	1.76	3.29
CD14-CD16+ Monocytes, donor3	11911-125G3	653.32	2.53	3.37	0.63	0.21	0.00	1.05	1.26	2.11
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	428.82	4.06	0.00	0.00	0.00	0.00	0.00	0.00	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	556.62	3.39	4.75	0.68	0.00	0.00	3.39	0.00	5.42
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	602.72	3.11	4.14	2.07	0.00	1.04	2.07	1.04	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	698.28	2.67	3.20	1.60	2.67	0.53	0.00	1.60	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	662.04	8.04	5.36	3.22	1.07	0.54	1.07	0.54	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	466.79	4.91	2.11	0.00	0.70	0.00	0.70	1.40	3.51
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	601.60	4.71	3.92	0.78	0.78	0.00	0.00	0.78	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	427.12	0.00	0.00	2.64	0.00	0.00	3.95	0.00	3.95
CD19+ B Cells, donor1	11544-120B5	1611.75	15.62	9.04	6.58	3.29	0.00	0.82	1.64	1.64
CD19+ B Cells, donor2	11624-122B4	1619.88	18.14	8.71	8.71	3.63	1.45	3.63	0.73	3.63
CD19+ B Cells, donor3	11705-123B4	1864.32	15.65	7.07	5.55	2.52	1.01	1.51	3.53	2.52
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1107.52	5.25	1.21	2.02	2.02	2.42	0.00	0.81	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	824.55	2.40	1.20	0.40	2.00	0.80	0.00	1.20	3.60
CD34+ Progenitors, donor1	11545-120B6	474.91	0.00	3.01	1.00	1.00	0.00	0.00	2.01	1.00
CD34+ Progenitors, donor2	11625-122B5	566.86	2.25	3.93	2.25	0.00	0.00	1.12	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	1223.08	3.38	2.63	1.13	1.13	0.00	1.50	1.88	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	594.83	2.71	2.25	1.58	1.13	0.00	0.23	0.68	1.58
CD4+ T Cells, donor1	11225-116C1	3409.89	9.28	8.57	3.57	2.86	0.71	4.28	4.28	1.43
CD4+ T Cells, donor2	11306-117C1	2099.18	14.08	11.02	4.29	6.12	1.22	3.06	7.96	7.35
CD4+ T Cells, donor3	11382-118B5	2177.65	19.21	13.72	7.93	3.05	0.30	2.13	5.18	4.88
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1662.61	6.89	9.95	4.85	2.55	0.77	0.51	1.79	1.28
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	1575.55	7.64	11.45	4.27	2.92	0.90	1.12	2.92	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	1434.14	8.05	6.90	2.87	1.15	0.29	0.29	1.72	1.72
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1363.01	6.64	1.90	0.95	0.47	0.47	3.79	1.90	4.74
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1358.29	6.32	0.70	0.70	0.00	0.00	0.70	2.81	9.13
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	1654.70	16.48	9.89	3.30	3.30	0.00	3.30	3.30	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	1005.54	8.53	6.65	2.89	1.45	0.43	0.29	0.72	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	741.40	4.91	5.76	2.71	2.88	0.51	1.02	2.03	2.20
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	556.80	3.06	2.90	0.97	1.45	0.00	0.97	1.29	1.61
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	892.11	5.38	2.69	1.34	1.34	0.00	0.90	2.24	2.69
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1032.44	2.80	5.24	3.14	2.10	0.35	1.05	2.45	3.49
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1048.04	7.48	3.96	1.76	3.52	0.44	0.88	1.32	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	1250.17	2.95	6.32	2.95	2.11	0.00	0.00	2.53	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	607.52	2.91	3.95	2.08	2.29	0.42	0.42	1.25	2.29
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	425.01	1.34	1.67	0.67	1.34	0.67	0.00	1.34	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2699.22	19.85	11.42	1.36	3.26	1.36	2.18	3.54	2.99
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	2809.98	19.83	6.97	3.75	3.22	2.68	5.36	2.68	3.22
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1825.50	10.76	10.76	5.38	10.76	0.00	5.38	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	1284.46	6.49	6.86	2.23	1.48	0.19	1.11	2.60	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	910.44	3.25	7.58	3.25	1.08	0.00	0.00	0.65	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	800.89	7.57	9.46	3.78	0.42	0.21	0.63	1.47	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	752.34	7.58	2.53	2.53	1.01	0.00	2.02	0.51	8.09
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	960.08	6.07	2.17	2.17	1.73	0.43	1.30	0.87	6.07
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1191.95	10.90	6.10	3.49	3.92	1.31	1.74	1.31	3.49
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	867.01	12.37	2.97	1.48	0.49	0.49	0.99	0.99	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	665.62	8.31	1.85	0.00	0.00	0.00	0.00	0.92	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	601.60	4.19	0.00	4.19	0.00	0.00	0.00	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	1445.01	9.14	6.65	4.15	0.55	0.00	0.55	0.00	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1548.91	8.34	6.63	1.23	1.23	0.00	0.25	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	947.10	1.54	1.54	0.00	4.62	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	1000.58	8.24	7.16	3.94	0.36	0.72	0.00	1.07	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	505.52	2.77	0.00	4.15	0.00	0.00	2.77	0.00	4.15
CD8+ T Cells, donor1	11226-116C2	2301.92	10.15	14.08	8.84	1.96	1.31	1.64	2.62	2.62
CD8+ T Cells, donor2	11307-117C2	1382.34	10.89	7.51	3.38	5.26	0.75	0.75	5.63	4.51
CD8+ T Cells, donor3	11383-118B6	1999.97	19.44	9.85	6.06	4.04	1.77	2.27	5.30	5.30
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	917.57	8.03	3.21	0.69	4.59	0.23	0.69	3.21	8.95
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	928.61	6.95	2.64	1.44	4.79	0.48	0.72	4.55	6.47
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	980.28	9.30	2.74	2.19	5.47	0.27	0.27	3.28	9.03
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	955.57	17.41	3.00	1.50	3.30	0.00	0.30	2.10	7.21
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	843.30	7.92	2.16	2.16	4.32	0.48	0.48	2.16	3.36
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	957.29	9.78	1.14	1.82	4.55	0.23	0.45	3.87	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	813.51	8.26	1.52	1.09	3.69	0.22	0.00	3.91	6.52
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	851.73	6.05	2.63	0.53	3.16	0.79	1.05	3.42	5.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	739.19	7.97	2.35	0.23	4.22	0.94	0.94	2.58	3.28
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	751.98	6.64	2.11	1.21	6.04	0.60	0.30	4.53	10.26
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	765.48	5.52	2.91	0.29	4.65	0.29	0.58	0.87	7.26
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	862.18	7.73	3.20	0.53	2.66	0.53	0.80	2.66	3.73
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	952.55	26.70	5.69	0.44	0.88	0.00	1.31	5.69	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	952.30	34.61	5.01	0.91	1.37	0.91	0.91	2.28	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	1442.52	68.62	8.20	0.00	2.24	0.75	0.00	5.22	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	1063.90	9.36	2.52	2.16	2.52	0.36	0.72	3.96	1.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	1046.44	8.06	2.01	2.30	3.45	0.86	2.01	5.18	3.16
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	1120.97	13.20	5.66	0.71	3.06	0.71	0.71	2.36	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	815.39	8.56	3.49	1.58	3.49	0.95	0.95	1.90	7.29
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	850.11	7.07	2.46	0.92	1.85	0.62	0.31	3.08	3.08
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	876.15	8.66	2.89	1.60	2.56	0.32	1.28	2.89	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	837.22	8.41	1.53	0.76	3.44	0.38	0.00	5.35	3.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	755.50	7.49	1.58	0.79	3.15	0.39	0.79	1.58	3.94
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	724.64	6.05	2.27	2.27	6.05	0.00	0.76	3.78	7.56
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	1026.18	49.78	4.82	2.41	3.21	0.00	0.00	7.23	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	1022.56	81.83	13.29	2.80	1.40	0.00	1.40	2.80	4.20
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	993.74	68.12	4.01	1.00	3.01	0.00	0.00	5.01	2.00
Cardiac Myocyte, donor1	11525-119I4	1553.58	0.00	3.66	1.83	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	475.81	1.48	0.99	0.49	1.48	0.49	0.00	0.49	2.47
Cardiac Myocyte, donor3	11686-122I3	976.45	3.26	1.26	0.95	1.05	0.00	0.00	0.42	1.05
Chondrocyte - de diff, donor1	11261-116G1	1660.88	4.16	8.67	4.85	1.73	0.35	0.35	1.39	0.00
Chondrocyte - de diff, donor2	11338-117F6	608.41	2.49	7.46	3.91	0.36	0.00	0.36	1.07	1.07
Chondrocyte - de diff, donor3	11410-118E6	765.50	7.62	10.70	3.98	2.73	0.23	0.00	2.50	2.62
Chondrocyte - re diff, donor2	11339-117F7	781.56	8.95	17.01	13.43	0.00	0.90	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	333.23	4.85	1.62	2.83	2.02	0.40	0.00	1.62	4.04
Ciliary Epithelial Cells, donor1	11242-116D9	810.88	5.51	2.18	1.03	1.26	0.57	0.00	0.92	1.15
Ciliary Epithelial Cells, donor2	11323-117D9	608.38	5.34	2.78	0.43	2.14	0.43	0.00	0.86	3.21
Ciliary Epithelial Cells, donor3	11399-118D4	685.68	4.34	1.77	1.33	1.50	0.27	0.18	1.06	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	613.75	7.79	4.03	6.88	1.01	69.05	93.26	0.64	0.55
Corneal Epithelial Cells, donor1	11526-119I5	535.32	2.42	2.20	0.88	0.66	0.22	0.00	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	352.66	0.00	4.55	1.14	1.14	0.00	0.00	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	575.42	3.58	2.30	1.53	1.79	0.00	0.00	0.77	1.53
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	739.13	4.79	4.13	2.48	1.49	0.99	0.17	4.13	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	573.10	2.84	2.84	2.52	1.26	0.95	0.00	1.89	2.21
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	327.82	0.00	0.00	0.00	3.45	0.00	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	793.94	5.72	4.21	3.46	2.92	0.54	0.22	2.05	2.48
Dendritic Cells - plasmacytoid, donor1	11228-116C4	1303.02	6.83	4.44	2.05	3.07	0.34	0.68	0.68	2.73
Dendritic Cells - plasmacytoid, donor2	11309-117C4	686.82	3.92	1.31	2.61	0.65	0.00	0.00	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	856.58	6.29	1.94	1.45	1.45	0.00	0.97	0.48	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	574.35	4.34	4.00	1.33	0.33	0.17	0.00	0.33	1.17
Endothelial Cells - Aortic, donor1	11263-116G3	420.13	3.52	2.35	0.59	0.00	0.00	0.59	0.59	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	647.89	3.96	3.39	0.57	1.13	0.00	0.00	1.98	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	610.61	3.15	4.33	1.57	1.18	0.00	0.00	0.39	2.75
Endothelial Cells - Artery, donor1	11264-116G4	592.22	7.27	3.78	3.20	0.58	0.00	0.00	1.16	0.58
Endothelial Cells - Artery, donor2	11341-117F9	507.73	4.24	2.82	1.65	0.71	0.00	0.24	2.82	1.18
Endothelial Cells - Artery, donor3	11413-118E9	693.70	3.86	7.01	4.21	0.88	0.00	0.00	1.05	2.45
Endothelial Cells - Lymphatic, donor1	11236-116D3	457.05	2.22	1.99	1.33	0.89	0.66	0.00	1.55	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	547.38	4.87	4.26	1.83	0.61	0.61	0.30	0.91	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	788.77	4.23	3.66	1.97	1.13	0.56	0.00	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	554.45	2.38	2.67	2.38	1.49	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	443.61	1.56	1.56	1.04	1.04	0.00	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	420.11	6.66	5.81	2.69	0.99	0.00	0.00	0.57	1.56
Endothelial Cells - Thoracic, donor1	11266-116G6	1107.53	5.60	6.00	2.00	0.80	0.80	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	285.65	0.52	1.05	0.00	0.00	0.00	0.00	0.00	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	1112.75	9.44	6.83	2.61	2.24	0.50	0.25	0.62	1.49
Endothelial Cells - Umbilical vein, donor2	11324-117E1	506.44	3.48	2.82	1.74	0.22	0.22	0.22	1.09	1.52
Endothelial Cells - Umbilical vein, donor3	11400-118D5	628.10	3.42	2.93	1.34	0.61	0.73	0.24	0.85	1.10
Endothelial Cells - Vein, donor1	11267-116G7	279.83	1.14	1.14	0.00	0.00	0.00	1.14	0.00	3.41
Endothelial Cells - Vein, donor2	11344-117G3	462.41	2.10	1.40	1.40	0.70	0.00	0.00	0.00	1.40
Endothelial Cells - Vein, donor3	11416-118F3	391.73	4.40	1.88	0.94	1.10	0.16	0.00	0.31	0.79
Eosinophils, donor1	12244-129H3	213.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	539.64	14.85	4.95	3.30	1.65	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	481.52	10.70	10.70	7.13	0.00	0.00	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	599.82	3.42	1.22	1.95	1.22	0.00	0.00	0.98	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	653.17	2.08	4.16	0.00	4.16	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	325.38	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	638.76	4.11	2.05	0.41	1.23	0.82	0.00	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	256.31	4.27	4.27	1.86	2.08	0.00	0.11	2.74	1.31
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	465.74	6.83	6.18	3.25	5.42	0.22	0.22	5.09	6.50
Fibroblast - Aortic Adventitial, donor1	11245-116E3	707.18	8.61	10.07	6.19	1.94	0.24	0.00	1.70	1.21
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	333.26	1.77	1.09	1.09	0.27	0.41	1.64	0.27	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	628.17	10.23	8.75	4.11	1.58	0.11	0.42	2.11	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	402.35	2.37	3.43	2.37	0.26	0.26	0.53	0.00	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	630.85	5.98	6.64	5.32	1.99	0.00	0.33	1.99	0.33
Fibroblast - Cardiac, donor1	11268-116G8	493.55	4.54	2.72	1.36	0.91	0.00	0.00	1.36	4.08
Fibroblast - Cardiac, donor2	11345-117G4	385.80	1.52	0.76	1.52	1.52	0.00	0.00	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	317.96	3.79	3.15	1.73	1.26	0.32	0.16	0.95	0.47
Fibroblast - Cardiac, donor4	11452-119A3	1177.27	11.82	6.37	4.55	0.91	0.61	0.30	2.12	0.00
Fibroblast - Cardiac, donor5	11456-119A7	583.89	3.43	2.79	1.78	0.38	0.25	0.00	0.00	0.76
Fibroblast - Cardiac, donor6	11460-119B2	598.04	2.58	1.21	0.91	0.61	0.45	0.30	0.15	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	1187.96	4.02	4.42	1.07	0.54	0.40	0.13	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	614.79	3.02	3.45	0.86	1.29	0.00	0.00	0.00	2.16
Fibroblast - Choroid Plexus, donor3	11653-122E6	445.30	1.46	1.46	1.46	1.46	0.00	0.00	1.46	10.25
Fibroblast - Conjunctival, donor1	11531-120A1	898.57	3.00	1.85	0.46	0.69	0.00	0.46	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	1686.38	7.29	6.11	3.05	2.20	0.17	0.00	1.19	2.04
Fibroblast - Dermal, donor1	11269-116G9	574.75	6.34	5.87	4.70	0.47	0.00	0.23	1.41	0.94
Fibroblast - Dermal, donor2	11346-117G5	570.26	2.83	0.47	0.47	0.47	0.00	0.00	0.47	0.94
Fibroblast - Dermal, donor3	11418-118F5	532.99	4.84	4.71	4.35	2.30	0.12	0.24	1.57	2.54
Fibroblast - Dermal, donor4	11450-119A1	691.84	2.71	1.24	0.90	0.79	0.57	0.23	0.68	0.90
Fibroblast - Dermal, donor5	11454-119A5	680.89	3.31	1.57	1.22	0.52	0.52	0.00	0.17	0.70
Fibroblast - Dermal, donor6	11458-119A9	872.38	4.06	1.46	0.49	0.32	0.49	0.32	0.65	0.49
Fibroblast - Gingival, donor1	11237-116D4	711.52	3.12	1.67	1.67	0.83	0.21	0.00	0.83	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	960.49	15.98	20.17	6.81	2.88	0.26	0.52	2.36	0.79
Fibroblast - Gingival, donor2	11318-117D4	478.11	3.56	0.66	0.53	0.79	0.26	0.00	0.53	1.32
Fibroblast - Gingival, donor3	11394-118C8	967.26	9.19	6.09	5.51	1.06	0.19	0.10	1.26	0.68
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	380.23	11.43	7.27	11.43	0.00	0.00	1.04	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	362.80	7.22	9.87	5.29	0.88	0.00	0.00	2.11	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	495.91	3.27	1.71	0.94	1.40	1.09	0.00	0.31	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	650.58	4.60	4.06	1.89	1.49	0.14	0.00	0.81	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	2893.96	33.17	32.11	7.76	0.35	0.71	0.35	1.76	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	798.20	5.12	7.75	3.22	1.61	0.58	0.29	0.88	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	776.67	6.14	5.18	2.32	1.09	0.68	0.14	0.82	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	946.65	7.13	8.67	3.18	1.21	0.00	0.33	1.76	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	828.19	12.47	22.45	7.48	1.76	0.44	0.15	2.35	0.73
Fibroblast - Lung, donor1	11270-116H1	222.93	0.00	4.08	1.36	0.00	0.00	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	790.84	2.98	10.45	1.49	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	373.32	2.11	1.69	1.69	0.84	0.21	0.21	0.21	2.32
Fibroblast - Lymphatic, donor1	11506-119G3	1726.85	3.33	2.50	0.83	0.83	0.00	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	997.22	4.20	2.80	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	295.55	1.40	0.84	0.00	0.84	0.28	0.00	0.56	0.56
Fibroblast - Mammary, donor1	11540-120B1	1725.37	7.31	7.71	1.62	0.41	0.00	0.00	0.81	1.22
Fibroblast - Mammary, donor2	11620-122A9	435.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	1381.85	17.87	11.91	0.00	0.00	0.00	0.00	11.91	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	670.18	2.91	2.33	0.39	0.58	0.78	0.00	1.16	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	892.04	6.07	4.10	1.52	0.61	1.21	0.30	1.67	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	1234.97	5.20	2.45	1.84	1.53	0.31	0.61	0.31	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	607.93	5.34	1.53	1.91	0.00	0.00	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	361.79	4.32	1.62	0.81	0.54	0.27	0.27	1.89	2.43
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	402.20	8.35	8.47	6.03	0.46	0.12	0.12	1.97	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	420.91	2.10	0.77	0.22	1.44	0.11	0.22	0.33	2.54
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	833.28	3.66	2.64	0.41	1.83	0.20	0.00	0.41	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	578.00	0.67	1.34	0.67	0.00	0.00	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	436.87	2.37	1.19	0.79	0.79	0.00	0.40	0.40	2.37
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	587.01	1.59	0.40	0.20	0.99	0.20	0.60	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	719.89	2.49	2.66	1.78	1.60	0.53	0.18	1.78	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	768.83	3.15	2.76	0.99	1.97	0.39	0.00	1.58	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	371.56	1.50	0.60	0.60	1.20	0.00	0.00	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	948.03	4.53	4.97	2.05	1.30	0.32	0.22	0.22	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	286.73	1.27	0.51	0.25	0.51	0.25	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	723.26	5.74	3.61	1.64	2.79	0.49	0.16	0.98	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	473.20	2.01	0.80	0.40	0.40	0.20	0.80	0.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	536.47	2.41	2.81	1.00	0.70	0.00	0.00	0.10	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	437.04	3.02	0.00	0.00	0.60	0.60	0.60	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	875.10	5.47	5.55	0.99	1.57	0.41	0.17	1.82	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	1183.15	6.33	8.55	2.39	2.22	0.85	0.17	0.51	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	345.18	1.31	0.00	0.33	0.33	0.00	0.33	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	452.18	2.02	1.92	0.96	0.43	0.21	0.11	0.21	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	515.49	1.35	1.69	0.17	1.01	0.17	0.34	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	228.02	8.31	4.23	1.41	5.02	0.31	0.31	3.92	7.53
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1772.78	22.16	22.16	22.16	44.32	0.00	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	1071.98	6.97	17.43	3.49	1.74	0.00	0.00	2.61	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	478.29	4.16	3.81	3.12	0.69	0.00	0.17	1.21	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	761.73	4.16	6.25	5.20	1.56	0.26	0.26	1.04	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	711.09	6.13	9.96	4.85	1.02	0.77	0.00	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	639.24	13.78	12.25	3.83	2.30	1.53	2.30	3.06	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	676.99	17.23	9.57	5.74	3.19	0.64	0.64	0.64	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	635.28	16.26	19.40	8.27	3.71	3.99	2.28	1.14	3.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	834.44	32.26	51.02	21.23	2.21	3.31	0.83	4.96	4.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	715.12	11.42	15.07	8.22	3.42	1.60	0.91	4.34	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	948.25	21.00	21.20	7.33	1.59	3.57	1.39	3.37	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	830.80	31.19	52.34	22.73	3.17	2.64	1.06	4.23	2.64
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	437.36	12.39	15.00	8.81	2.61	1.30	1.30	3.59	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	712.86	14.15	24.32	8.84	2.65	2.21	2.65	0.88	7.08
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	1013.70	12.15	3.67	5.37	2.26	0.99	0.85	2.40	1.70
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	811.02	8.50	6.16	2.96	1.35	1.23	0.25	2.34	2.22
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	787.34	9.94	4.84	3.49	1.61	2.15	0.54	1.61	2.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	760.95	7.06	5.08	4.46	2.23	1.61	0.12	1.36	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	939.22	8.31	4.71	2.77	2.91	1.38	0.83	3.32	1.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	933.16	6.30	5.08	4.07	2.64	1.42	0.20	2.03	2.85
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	626.12	6.85	3.19	2.74	1.37	1.37	0.46	2.05	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	806.56	9.72	6.98	4.73	1.37	1.49	0.37	1.49	2.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	963.92	15.96	5.90	6.78	1.31	1.53	0.66	2.62	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	608.98	6.50	7.68	2.07	2.66	1.48	0.00	0.89	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	689.56	7.15	3.02	2.86	2.38	1.43	0.32	0.79	2.38
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	714.05	10.72	6.26	5.81	1.79	0.45	0.22	0.89	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	556.71	5.24	4.64	5.04	1.01	0.60	0.20	1.81	1.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	589.51	4.75	3.56	2.54	1.02	0.85	0.00	1.87	2.04
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	1212.41	12.15	10.20	6.56	1.77	1.33	0.09	1.15	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	1915.15	28.30	19.15	12.17	1.77	2.19	0.31	2.60	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	1729.45	23.57	12.30	5.64	1.54	1.20	0.34	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	690.15	7.64	3.98	5.31	1.33	0.66	0.11	1.11	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	957.26	7.07	6.57	4.24	1.16	0.83	0.25	1.58	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	899.62	5.72	4.90	2.45	1.84	0.82	0.20	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	561.56	5.57	3.92	5.16	1.03	0.62	0.41	1.03	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	712.05	7.49	5.65	3.69	1.27	0.58	0.23	1.50	1.15
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	557.49	6.84	5.00	3.67	0.83	0.83	0.00	1.33	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	556.37	6.61	5.07	5.51	0.88	1.10	0.22	1.54	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	774.97	9.35	6.27	2.71	2.09	0.37	0.12	2.21	1.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	491.47	4.54	3.08	2.59	0.81	1.13	0.00	0.49	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	716.16	10.58	10.58	4.81	0.00	1.60	0.32	1.92	2.25
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	462.97	5.69	4.36	2.75	1.04	0.47	0.00	1.33	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	538.59	6.96	4.59	2.21	0.79	0.32	0.16	1.74	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	476.20	7.30	6.39	4.26	0.61	1.22	0.30	2.43	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	414.81	5.54	4.29	3.55	0.94	0.63	0.21	0.52	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	581.16	7.25	5.49	4.83	1.10	1.10	0.00	1.54	2.20
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	429.80	5.89	4.21	3.93	0.56	0.56	0.28	0.84	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	455.07	6.76	2.87	3.15	0.93	0.37	0.09	0.93	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	370.89	4.01	2.41	2.14	1.34	0.80	0.00	0.80	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	399.65	4.13	1.68	1.22	0.92	0.31	0.00	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	367.11	2.46	2.20	1.17	1.30	0.52	0.26	0.52	1.94
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	494.98	5.42	4.88	3.25	1.90	0.27	0.27	1.36	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	438.02	2.40	3.32	1.66	0.92	0.55	0.55	1.47	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	407.92	5.70	2.19	1.75	1.32	0.22	0.22	2.41	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	1587.79	6.94	9.92	5.95	0.99	0.00	0.99	4.96	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	375.95	3.43	3.30	1.45	1.06	0.13	0.26	0.66	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	348.23	3.03	1.82	1.61	0.81	0.40	0.00	1.41	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	2343.35	20.08	15.00	7.88	0.51	2.29	0.00	0.76	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	1684.45	8.16	9.95	2.59	2.79	2.59	1.19	0.80	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	1062.82	12.17	6.01	4.47	2.16	1.69	1.08	1.85	3.24
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1397.10	8.80	5.93	4.91	2.25	1.43	3.48	1.02	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	562.34	2.19	2.82	1.88	1.56	0.94	1.25	1.25	2.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	544.48	3.11	3.96	2.54	1.70	1.70	0.28	1.41	1.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	751.76	4.61	2.31	5.07	4.15	1.38	0.46	0.92	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	534.56	4.95	9.90	0.00	14.85	0.00	0.00	0.00	14.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	683.88	3.87	4.64	3.48	1.93	0.77	1.16	2.32	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	545.52	0.00	1.60	3.21	1.60	0.00	0.00	0.00	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	537.30	8.69	5.22	3.48	3.48	0.00	0.00	8.69	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	520.44	4.23	11.39	1.95	3.25	1.95	0.33	1.30	4.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	676.59	3.71	4.12	2.88	1.24	1.65	0.00	2.06	4.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	653.12	16.66	23.33	10.00	6.66	3.33	0.00	6.66	29.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	542.24	4.47	9.51	3.92	3.08	0.56	0.00	1.68	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	609.24	5.23	7.19	4.90	2.29	0.33	0.00	2.61	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	572.93	10.07	12.58	3.36	7.55	0.00	0.84	3.36	25.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	660.32	4.13	9.54	3.82	2.86	1.27	0.32	1.91	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	563.84	3.74	3.40	2.38	2.04	2.04	0.68	1.36	3.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	390.48	6.26	4.18	2.09	4.18	0.00	0.00	6.26	10.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	794.33	8.02	9.16	2.29	3.44	1.15	0.57	1.15	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	503.47	2.07	4.44	2.37	2.96	0.59	0.00	0.59	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	387.96	5.08	5.08	1.69	5.08	0.00	0.00	3.39	11.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	570.78	3.31	7.87	2.07	2.90	0.00	0.41	0.83	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	694.76	5.06	6.21	4.60	3.22	0.69	0.46	2.07	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	268.69	10.54	0.00	10.54	0.00	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	450.53	2.31	2.69	0.77	1.54	0.77	0.00	0.77	4.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	411.70	2.61	4.24	3.59	1.96	0.65	0.00	0.98	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	343.11	2.68	6.02	5.35	2.01	0.00	0.00	2.01	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	673.45	3.85	8.86	4.62	2.31	0.39	1.16	1.93	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	906.52	3.77	9.59	3.77	2.74	1.03	0.68	2.05	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	559.08	14.91	24.85	14.91	14.91	4.97	0.00	0.00	17.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	714.38	7.55	10.85	6.61	3.30	1.89	0.00	2.36	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	646.34	7.85	9.66	3.02	4.83	3.02	0.00	1.81	6.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	627.20	6.61	15.26	9.66	3.56	2.54	0.51	2.54	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	623.78	9.57	11.17	11.17	3.19	0.00	0.00	1.60	5.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	546.64	4.44	3.45	4.44	2.96	0.99	0.00	1.48	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	514.67	2.36	2.36	1.18	4.72	0.00	0.00	0.00	15.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	423.58	3.50	7.58	3.50	4.08	1.17	0.00	1.75	7.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	638.13	3.51	12.73	3.51	4.83	1.76	0.00	2.19	3.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	402.65	3.39	2.54	0.00	5.93	0.00	0.00	0.85	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	225.04	3.58	2.39	0.60	2.39	0.00	0.00	1.79	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	320.75	2.91	4.37	0.97	0.97	0.00	0.00	2.43	5.82
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	271.63	2.28	2.28	0.00	0.00	0.00	0.00	1.14	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	290.24	3.33	1.66	0.42	0.00	0.00	0.00	0.00	2.91
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	267.62	2.25	4.50	5.62	0.00	0.00	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	724.71	4.12	1.90	0.63	0.63	0.32	0.00	1.27	2.54
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	476.64	1.67	1.67	0.84	1.25	0.42	0.00	0.42	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	474.15	2.20	0.93	0.35	1.51	0.70	0.81	0.93	1.28
Hep-2 cells mock treated, biol_rep2	11899-125E9	464.37	1.52	1.18	0.68	1.01	0.51	0.84	0.51	1.35
Hep-2 cells mock treated, biol_rep3	11900-125F1	465.47	2.28	1.14	0.46	1.82	0.46	0.23	0.46	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	445.32	3.28	1.31	0.66	1.31	0.77	0.77	0.44	2.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	484.84	2.79	3.22	0.43	0.86	0.00	0.64	0.21	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	447.57	2.37	1.08	0.43	1.29	0.86	0.43	0.86	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	390.18	1.74	0.75	0.25	1.74	1.25	0.50	0.37	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	426.82	2.74	0.51	0.69	1.20	0.86	0.34	0.17	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	384.77	1.60	0.32	0.96	0.64	0.64	0.00	0.96	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	801.94	9.51	11.75	3.92	0.56	0.56	0.00	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	560.04	3.03	5.63	2.16	0.87	0.00	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	544.62	5.29	0.00	0.00	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	644.42	2.12	2.12	0.71	1.06	0.00	0.00	1.06	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	448.26	3.63	2.91	1.45	0.00	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	359.99	2.27	0.35	0.52	1.22	0.00	0.00	0.35	3.67
Hepatocyte, donor1	11523-119I2	300.23	0.00	4.84	1.21	2.42	0.00	0.00	0.00	3.63
Hepatocyte, donor2	11603-120I1	373.84	0.00	4.31	2.15	0.00	0.00	0.00	1.08	2.15
Hepatocyte, donor3	11684-122I1	461.99	4.91	17.18	4.91	0.61	0.00	1.84	0.61	3.07
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	895.49	4.57	1.31	0.65	1.31	0.65	1.96	0.65	3.92
Intestinal epithelial cells (polarized), donor1	11246-116E4	593.56	5.07	4.89	2.62	1.40	0.17	0.17	0.70	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	900.21	3.16	1.37	1.37	1.23	0.00	0.14	0.41	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	165.56	3.18	3.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	186.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	352.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	232.58	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	237.75	0.00	0.00	2.50	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	510.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	212.72	2.56	0.00	0.00	0.00	2.56	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	155.41	0.00	9.14	0.00	0.00	0.00	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	237.15	0.00	0.00	0.00	0.00	0.00	3.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	256.77	6.67	0.00	0.00	0.00	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	239.62	3.63	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	207.78	0.00	2.65	0.00	0.00	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	260.53	1.11	0.00	1.11	1.11	0.00	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	246.20	0.00	0.00	0.00	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	256.98	1.89	0.63	1.26	1.26	1.26	1.89	0.63	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	231.99	3.09	0.00	0.00	1.55	1.55	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	190.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	231.93	2.58	0.65	0.00	0.65	1.29	0.00	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	194.80	3.22	0.00	0.00	0.00	0.00	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	143.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	275.43	4.89	0.00	1.63	0.81	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	242.23	2.94	0.42	0.00	0.00	0.42	0.84	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	0.00	0.00	0.00	0.00	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	275.66	1.61	0.00	0.00	0.00	0.80	1.61	2.41	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	242.82	0.92	0.00	0.92	0.00	0.92	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	273.31	1.42	0.00	1.42	1.42	0.00	1.42	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	264.84	0.91	0.00	0.00	0.00	0.00	0.00	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	309.59	0.00	0.00	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	203.39	1.08	1.08	0.00	1.08	0.00	2.15	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	212.17	0.00	1.27	0.00	2.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	147.87	0.00	0.00	0.00	0.00	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	239.77	3.19	0.64	0.00	0.64	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	207.78	3.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	237.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	227.79	2.14	3.57	0.00	0.00	0.71	0.00	0.71	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	179.19	3.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	341.69	1.85	0.62	0.31	1.23	0.62	0.93	0.62	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	214.23	0.00	1.76	0.00	0.00	0.00	0.00	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	238.88	3.14	0.00	3.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	170.37	0.70	0.00	0.00	0.70	0.00	0.70	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	267.78	0.00	0.00	0.00	0.00	0.00	0.00	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	278.81	3.24	0.00	0.00	0.00	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	230.19	4.36	1.74	0.00	0.00	0.00	1.74	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	220.48	2.25	0.00	0.00	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	149.84	3.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	215.49	2.13	1.07	0.00	0.00	0.00	0.00	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	231.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	170.98	2.85	0.00	0.00	0.00	0.00	0.00	2.85	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	194.21	0.92	1.84	1.84	1.84	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	178.49	6.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	180.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	237.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	802.45	5.06	8.16	4.08	1.39	0.16	0.24	0.73	0.00
Keratinocyte - epidermal, donor2	11349-117G8	479.64	1.17	1.17	1.17	1.17	0.00	0.59	0.59	2.34
Keratinocyte - epidermal, donor3	11421-118F8	547.11	2.93	1.70	1.23	0.95	0.09	0.09	1.04	2.18
Keratinocyte - oral, donor1	11251-116E9	1401.60	8.85	3.41	2.50	2.38	0.11	0.00	2.61	1.70
Keratocytes, donor1	11527-119I6	667.72	3.44	0.69	0.34	0.34	0.00	0.00	0.69	0.00
Keratocytes, donor2	11607-120I5	533.17	0.00	1.17	0.00	1.17	0.00	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	641.99	8.50	4.54	2.77	0.59	0.00	0.00	1.78	1.78
Krukenberg tumor cell line:HSKTC	10687-109F3	268.15	2.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	422.87	2.16	2.16	0.00	1.08	0.00	0.00	0.00	4.31
Lens Epithelial Cells, donor2	11609-120I7	1010.08	3.23	0.92	1.15	1.61	0.12	0.12	0.81	0.23
Lens Epithelial Cells, donor3	11690-122I7	1126.86	3.63	1.11	0.30	0.81	0.10	0.00	1.11	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	620.16	2.96	3.32	1.19	0.71	0.47	0.24	0.47	1.90
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	336.01	2.23	1.95	1.40	1.40	0.00	0.00	1.95	4.19
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	540.08	5.04	3.31	2.36	1.26	0.31	0.00	1.10	5.82
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	234.98	1.08	1.08	0.54	0.54	0.54	0.00	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	383.24	3.78	2.84	1.58	2.21	0.32	0.00	0.95	1.89
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	341.34	2.16	2.91	0.43	0.54	0.00	0.11	0.75	2.59
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	280.30	2.46	2.46	0.41	0.41	0.00	0.00	0.00	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	234.62	1.26	0.76	0.25	0.00	0.00	0.00	0.25	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	392.55	2.39	3.66	1.41	0.42	0.14	0.00	0.70	2.82
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	283.20	1.19	1.98	0.00	0.40	0.00	0.00	0.79	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	372.26	3.10	3.30	1.36	0.78	0.39	0.19	0.78	2.71
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	196.26	1.30	1.11	0.74	0.93	0.19	0.00	0.56	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	258.88	1.39	2.09	0.35	1.05	0.00	0.00	0.35	3.14
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	359.69	1.67	1.91	0.95	0.95	0.48	0.00	0.24	3.82
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	294.47	3.02	2.06	0.55	0.27	0.00	0.00	0.82	3.16
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	287.33	2.16	0.62	1.54	1.23	0.00	0.00	0.31	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	244.72	0.94	1.87	0.00	1.25	0.00	0.00	0.31	4.68
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	439.54	2.93	2.74	1.10	0.91	0.18	0.18	0.73	2.74
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	283.36	0.99	0.66	0.00	2.30	0.00	0.00	0.66	2.63
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	289.36	2.05	2.05	0.29	0.59	0.00	0.00	1.17	2.93
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	307.92	1.74	1.49	1.00	1.00	0.00	0.00	1.00	1.99
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	303.10	1.45	1.45	0.48	0.97	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	383.48	1.89	4.31	0.81	0.27	0.27	0.00	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	439.00	3.18	4.09	1.97	1.06	0.00	0.00	1.06	1.97
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	282.53	1.04	1.04	0.00	0.00	0.00	0.00	0.00	3.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	386.95	2.09	2.30	1.26	1.47	0.21	0.00	0.84	2.93
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	362.85	3.31	2.56	1.35	1.50	0.15	0.00	1.80	3.91
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	314.36	1.38	4.13	0.00	0.00	0.69	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	337.91	2.26	2.07	1.32	0.75	0.00	0.00	0.75	1.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	308.02	2.86	2.65	1.06	0.32	0.21	0.00	0.53	2.01
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	296.08	0.97	0.97	0.00	0.48	0.48	0.00	1.45	2.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	300.69	3.97	1.98	0.99	0.33	0.00	0.00	0.00	2.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	337.11	3.22	2.60	0.99	0.99	0.12	0.00	0.74	3.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	367.99	2.96	3.33	1.11	0.37	0.37	0.00	2.22	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	300.45	3.46	2.47	0.49	0.99	0.00	0.00	0.49	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	294.92	1.79	1.79	1.24	0.96	0.14	0.00	0.27	1.92
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	343.51	1.29	2.25	1.61	1.29	0.32	0.00	0.64	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	458.02	3.04	3.04	1.83	1.52	0.30	0.00	0.61	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	428.16	1.82	3.78	1.26	0.84	0.56	0.00	0.84	5.04
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	280.54	1.78	2.49	1.07	0.36	0.36	0.00	0.71	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	245.30	1.94	0.97	0.48	1.45	0.00	0.00	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	291.30	1.87	2.33	0.47	0.62	0.00	0.00	0.00	2.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	224.53	0.36	0.00	0.00	0.72	0.36	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	338.76	1.31	2.94	0.65	0.65	0.00	0.00	0.33	1.96
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	244.84	1.18	1.88	1.18	0.94	0.00	0.00	0.24	2.59
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	617.77	4.46	4.08	1.36	0.37	0.12	0.00	0.74	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	256.38	2.31	2.56	0.51	0.77	0.26	0.00	0.51	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	365.79	1.19	1.79	0.90	0.90	0.30	0.00	0.00	2.39
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	140.49	4.53	4.53	2.27	4.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	713.43	4.60	1.53	0.77	3.07	0.00	0.00	5.37	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	567.06	0.74	0.74	2.23	1.48	0.00	0.00	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	558.95	2.54	2.12	1.69	3.39	0.42	1.27	2.54	2.96
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	497.25	6.33	2.81	0.70	1.41	0.70	0.70	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	474.45	2.80	0.00	0.00	2.80	0.00	2.80	2.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	453.44	1.55	2.06	1.03	1.55	0.00	0.00	2.58	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	416.31	1.19	2.38	1.19	1.19	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	528.39	2.26	2.26	0.90	0.45	0.00	1.36	1.13	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	1006.85	6.69	3.78	2.91	5.53	0.58	0.29	2.91	4.94
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	1048.46	10.80	3.60	2.25	8.55	0.00	0.00	6.30	4.50
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	770.24	6.50	3.93	1.90	2.17	0.41	0.54	0.95	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	600.31	4.11	3.59	0.00	5.14	0.00	2.57	2.57	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	966.47	5.29	5.29	2.12	4.59	0.35	0.00	5.29	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	814.22	0.67	3.33	2.67	5.33	0.00	0.00	0.67	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	677.99	5.09	3.57	1.02	5.09	1.02	0.00	1.53	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1106.44	7.20	3.74	1.87	6.94	1.07	0.27	4.80	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	1061.49	10.20	3.78	2.46	3.02	0.57	0.38	1.51	3.78
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	533.80	3.68	2.45	2.45	3.68	0.00	0.61	1.84	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	746.11	12.23	4.08	4.89	2.45	0.00	0.00	5.71	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	1094.73	7.08	2.92	1.46	3.96	0.62	0.42	4.79	5.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	1098.34	8.41	3.92	4.76	10.37	0.56	0.56	3.92	4.20
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	691.36	5.15	3.09	1.03	4.12	0.00	1.03	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	964.68	9.00	5.52	3.19	6.97	0.87	0.58	6.97	13.64
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	995.44	4.48	3.29	1.79	4.78	2.09	0.00	2.09	2.99
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1045.10	7.75	3.87	2.77	7.19	0.00	1.11	1.66	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	768.83	6.72	3.89	1.06	4.24	0.35	0.71	2.12	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	886.92	5.90	2.95	1.48	2.95	0.74	0.74	2.21	2.95
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	526.13	5.76	3.45	3.45	3.45	0.00	0.00	2.30	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	607.48	4.61	1.15	3.07	4.61	0.38	0.77	1.92	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	609.16	5.10	5.66	3.96	6.79	0.00	0.00	3.40	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	754.01	4.92	2.46	0.82	0.82	0.00	0.82	4.10	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	530.51	3.16	1.81	1.36	3.62	0.00	0.90	2.26	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	733.94	7.18	5.03	3.59	2.15	0.00	0.00	3.59	5.03
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	996.37	10.46	3.73	3.73	4.48	0.75	0.00	1.49	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	601.24	7.06	4.83	1.49	2.60	2.23	0.00	2.60	4.46
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	893.80	5.17	3.02	2.15	3.88	1.29	0.00	1.72	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	835.75	5.14	5.14	2.57	5.99	0.00	0.00	4.28	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	813.29	8.33	2.33	1.67	5.00	1.00	0.33	4.66	5.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	639.51	7.24	5.43	0.00	3.02	1.21	0.60	2.41	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	544.62	3.55	2.84	0.71	2.13	0.00	0.71	2.84	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	678.15	5.84	3.09	0.34	3.09	0.69	0.34	3.09	2.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	618.33	5.90	1.07	1.07	5.90	0.54	0.54	3.22	4.29
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	593.90	3.37	2.69	0.00	3.37	0.00	0.00	4.04	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	786.75	5.56	4.44	4.07	4.44	0.74	0.37	3.33	2.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	155.83	4.65	0.00	0.00	0.00	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	445.31	7.40	2.12	1.06	0.00	1.06	1.06	3.17	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	717.07	8.00	1.20	2.00	3.60	1.20	0.80	3.60	3.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	430.31	4.36	0.00	0.73	3.63	0.73	2.91	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	466.81	3.83	1.53	1.53	2.30	0.77	3.07	2.30	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	543.10	3.45	2.96	1.97	3.95	0.49	0.49	4.93	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	507.16	0.94	2.82	0.00	1.88	0.00	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	476.67	2.51	2.01	1.01	3.02	0.50	0.00	2.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	583.56	6.31	1.80	1.35	5.86	0.45	1.80	0.45	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	464.70	3.44	1.72	0.00	5.16	3.44	1.72	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	671.13	3.56	1.34	1.34	4.45	1.34	2.23	3.56	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	582.63	3.91	0.78	1.56	4.30	0.78	1.17	2.35	2.74
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	608.94	3.30	3.96	0.00	4.62	0.66	0.00	2.64	4.62
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	557.33	2.59	1.56	1.56	3.63	1.04	1.56	1.04	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	422.25	6.56	1.75	1.31	4.38	0.88	0.00	3.06	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	841.45	5.59	5.59	0.56	7.83	1.68	0.00	0.00	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	643.91	4.86	2.65	1.32	1.77	0.00	1.32	2.65	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	765.64	8.87	5.01	1.16	3.86	0.00	0.77	4.63	3.86
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	766.11	3.04	2.53	1.52	7.09	0.00	0.51	5.06	3.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	756.50	2.40	2.40	2.88	1.92	0.00	1.44	1.92	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	737.45	4.77	3.18	0.40	5.57	0.40	1.19	4.77	2.39
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	924.80	1.22	4.86	0.61	3.04	0.61	0.61	1.82	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	726.98	7.61	2.77	0.69	1.38	0.69	0.69	0.69	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	747.44	6.08	2.66	3.80	3.04	0.00	0.76	2.66	4.18
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	753.45	7.75	3.10	1.03	4.13	0.52	0.52	3.10	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	655.45	3.63	0.60	1.21	2.42	1.21	0.60	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	817.29	6.97	3.49	4.44	4.12	0.95	1.58	3.80	3.80
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	536.82	2.13	3.20	0.00	4.26	0.53	0.53	1.07	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	503.41	2.87	4.02	1.72	0.57	3.45	0.57	1.72	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	669.02	6.69	1.54	1.54	4.63	0.51	1.03	4.63	3.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	682.60	4.95	1.41	1.41	4.95	0.00	0.00	3.54	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	603.24	3.97	2.27	1.13	1.13	1.13	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	679.37	4.58	2.08	2.08	4.99	0.42	0.00	2.50	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	670.28	6.26	3.92	2.35	2.35	0.78	0.00	2.35	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	603.77	3.34	1.67	0.84	3.34	0.42	0.42	0.42	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	536.19	6.97	2.32	0.00	2.32	0.00	0.46	0.46	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	570.03	4.01	1.34	0.67	0.00	0.00	0.67	1.34	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	755.98	2.67	3.21	0.00	1.07	0.00	1.07	2.14	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	416.62	2.42	3.23	1.62	3.23	0.40	1.21	2.02	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	457.96	3.67	1.84	0.92	2.75	0.92	0.00	0.00	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	648.16	1.78	4.45	0.00	3.56	0.89	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	558.47	5.70	0.57	1.14	0.57	0.57	0.00	2.85	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	513.82	1.53	1.53	0.77	3.83	1.53	0.00	2.30	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	1059.88	4.92	6.02	3.83	2.74	0.55	0.55	2.19	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	538.55	3.56	1.78	1.78	1.78	0.00	0.45	2.23	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	604.40	7.28	1.82	1.82	1.04	0.26	0.52	1.56	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	599.45	1.33	3.98	1.33	1.33	0.66	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	829.37	4.16	2.08	0.00	8.31	2.08	4.16	10.39	0.00
Macrophage - monocyte derived, donor1	11232-116C8	432.58	2.51	1.60	1.14	0.91	0.68	0.00	1.60	1.37
Macrophage - monocyte derived, donor2	11313-117C8	347.75	3.12	0.92	0.55	0.37	0.73	0.00	0.55	0.55
Macrophage - monocyte derived, donor3	11389-118C3	436.89	2.36	1.84	1.05	0.79	0.39	0.00	1.05	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	225.68	0.00	0.00	0.53	0.53	0.00	0.00	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	557.28	4.12	3.64	0.95	0.79	0.16	0.00	0.95	0.48
Mallassez-derived cells, donor3	11930-125I4	594.31	3.89	2.64	1.81	0.97	0.14	0.14	0.83	0.14
Mammary Epithelial Cell, donor1	11273-116H4	1079.14	1.89	1.40	1.69	1.20	0.20	0.20	1.10	1.10
Mammary Epithelial Cell, donor2	11350-117G9	638.17	2.61	1.16	0.29	1.74	0.00	0.58	1.16	0.29
Mammary Epithelial Cell, donor3	11422-118F9	399.83	2.00	2.74	1.00	1.25	0.00	0.00	0.25	2.24
Mast cell - stimulated, donor1	11487-119E2	780.30	24.41	32.54	14.91	0.68	0.00	0.00	0.68	0.68
Mast cell, donor1	11563-120D6	1255.95	11.79	14.38	9.52	1.19	0.22	0.00	1.41	0.11
Mast cell, donor2	11565-120D8	1332.83	25.26	21.10	19.32	0.89	1.19	0.30	4.16	0.30
Mast cell, donor3	11566-120D9	1678.98	26.79	31.07	19.36	1.13	0.90	0.00	6.53	0.23
Mast cell, donor4	11567-120E1	1310.17	28.37	23.76	21.81	0.35	1.42	0.00	6.03	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	993.49	6.32	7.32	5.10	1.22	0.22	0.22	0.89	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	882.53	12.84	14.01	7.00	1.17	0.00	0.00	1.75	0.58
Mast cell, expanded, donor5	11939-126A4	499.96	7.46	8.26	4.47	1.03	0.00	0.00	1.72	0.46
Mast cell, expanded, donor8	11941-126A6	874.33	18.41	17.74	14.90	1.67	0.50	0.17	3.01	0.17
Melanocyte - dark, donor1	11502-119F8	876.78	2.69	1.79	1.59	0.99	0.30	0.00	0.90	0.50
Melanocyte - dark, donor2	11582-120F7	450.60	1.38	1.38	0.00	0.35	0.00	0.00	0.00	3.11
Melanocyte - dark, donor3	11663-122F7	574.02	1.59	0.87	1.30	0.58	0.36	0.07	0.43	0.43
Melanocyte - light, donor1	11274-116H5	370.00	6.11	7.76	2.12	0.24	0.24	0.00	0.94	0.00
Melanocyte - light, donor2	11351-117H1	350.79	5.46	6.82	5.46	0.68	0.00	0.00	1.36	0.00
Melanocyte - light, donor3	11423-118G1	319.14	11.27	2.60	2.60	0.87	0.00	0.00	2.60	5.20
Melanocyte, donor1 (MC+1)	12641-134G4	292.70	2.39	1.98	0.62	0.62	0.10	0.10	0.83	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	283.73	4.30	1.34	1.88	1.08	0.27	0.00	1.34	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	624.64	9.64	8.30	2.68	2.14	0.00	0.27	1.61	0.00
Meningeal Cells, donor1	11493-119E8	1460.56	3.97	2.73	0.62	0.99	0.50	0.00	0.37	0.12
Meningeal Cells, donor2	11573-120E7	1202.48	3.08	4.40	1.32	0.88	0.88	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	1021.62	4.65	1.22	0.82	1.39	0.41	0.00	0.65	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	504.44	2.00	1.14	0.29	1.43	0.29	0.00	0.29	1.71
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	554.78	3.72	2.82	1.11	0.70	0.10	0.60	0.40	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	470.47	2.63	5.26	3.94	0.00	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	211.92	0.00	0.00	0.00	1.31	1.31	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	253.31	3.59	0.00	0.72	0.72	0.00	0.00	1.44	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	446.41	3.39	4.87	1.69	0.85	0.00	0.00	0.64	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	377.99	3.52	3.52	2.01	1.01	0.00	0.00	2.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	518.84	1.54	0.66	0.00	1.10	0.44	0.00	0.66	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	425.20	2.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	416.37	2.86	0.82	0.41	0.41	0.20	0.00	0.20	1.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	1056.53	2.35	3.74	0.97	1.39	0.00	0.14	0.55	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	383.25	1.49	1.86	0.37	0.74	0.00	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	1297.32	5.26	3.16	2.37	2.50	0.00	0.00	0.79	2.11
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	632.65	3.26	2.37	0.89	1.48	0.30	0.00	1.19	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	551.19	7.01	2.34	0.00	2.34	0.00	0.00	2.34	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	747.99	1.28	1.28	0.64	1.92	0.64	0.00	0.00	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	393.79	1.42	1.06	1.42	0.00	0.00	0.35	0.35	3.19
Mesenchymal stem cells - hepatic, donor0	11218-116B3	747.10	2.50	1.25	1.25	1.56	0.31	0.00	0.00	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	337.45	3.63	0.00	1.45	1.45	0.00	0.00	1.45	3.63
Mesothelial Cells, donor1	11247-116E5	378.67	3.45	5.57	2.39	0.00	0.00	0.27	1.06	0.53
Mesothelial Cells, donor2	12156-128G5	174.66	0.50	2.50	1.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	391.75	3.97	4.41	2.10	0.72	0.14	0.36	1.08	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	398.35	1.35	0.00	0.00	0.00	1.35	0.00	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	416.45	2.22	1.48	1.72	0.25	0.74	0.25	1.23	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	321.55	1.77	2.06	1.18	0.29	0.59	0.59	1.47	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	41.48	0.00	0.00	0.00	0.00	0.00	0.00	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	252.61	0.62	0.00	0.93	0.62	0.31	0.00	0.31	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	303.06	1.04	1.24	1.04	0.41	0.21	0.00	0.41	1.45
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	53.27	2.32	0.00	2.32	0.00	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	344.61	4.75	3.00	1.00	0.25	0.50	0.00	2.50	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	346.78	4.19	2.33	0.47	0.00	0.00	0.00	1.40	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	352.99	3.86	1.22	0.20	0.41	0.61	0.00	1.22	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	306.87	4.75	0.79	0.00	0.79	1.19	0.40	0.79	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	42.76	0.00	0.00	0.00	0.00	0.00	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	292.91	7.96	0.00	1.77	0.88	0.00	0.00	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	305.85	4.94	2.28	0.00	0.76	0.76	0.00	1.14	2.28
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	51.32	40.79	2.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	302.21	21.65	2.55	0.85	1.49	1.06	0.21	0.42	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	139.04	5.52	2.76	0.00	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	303.72	24.14	2.68	0.60	0.60	0.60	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	122.40	6.71	0.00	0.00	0.00	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	294.81	22.83	1.51	1.51	1.00	0.75	0.00	0.75	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	272.60	8.79	0.71	0.48	0.48	0.71	0.00	0.24	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	60.82	45.34	2.21	0.55	0.00	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	271.00	18.88	1.15	0.23	0.69	0.00	0.00	1.15	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	275.33	12.20	1.26	0.84	0.42	0.42	0.00	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	315.53	41.99	3.06	0.82	0.41	0.61	0.00	1.43	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	272.25	18.45	1.07	0.64	0.21	0.43	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	260.97	11.11	1.33	0.22	0.22	0.44	0.22	0.67	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	51.59	0.00	0.00	0.00	0.00	0.00	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	222.96	24.53	1.97	0.00	0.44	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	224.07	16.73	3.04	0.51	0.00	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	51.37	26.51	4.97	0.00	0.00	0.00	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	229.12	42.67	1.36	0.27	0.54	0.82	0.00	1.09	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	284.08	11.47	2.65	0.59	0.59	0.29	0.29	1.18	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	63.24	17.45	2.18	1.09	0.00	0.00	0.00	4.36	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	188.38	10.09	0.96	0.96	1.44	0.00	0.00	0.48	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	252.94	9.21	3.20	1.20	0.40	0.40	0.00	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	139.86	5.48	1.37	0.00	0.00	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	238.27	8.01	1.00	0.50	0.50	0.00	0.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	134.74	0.00	0.00	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	114.16	12.23	0.00	0.00	0.00	0.00	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	206.26	3.50	0.88	0.00	0.00	0.00	0.00	0.44	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	75.05	3.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	170.34	5.76	0.00	0.00	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	278.41	4.46	1.24	0.25	0.50	0.50	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	131.52	4.87	0.70	0.00	0.00	0.00	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	55.25	4.42	2.21	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	204.44	1.37	0.68	0.00	0.00	0.00	0.34	1.37	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	119.91	1.31	0.00	0.00	0.00	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	135.29	1.07	0.36	0.00	0.36	0.00	0.00	1.07	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	221.36	2.24	0.56	0.56	0.56	0.28	0.00	0.28	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	97.26	0.42	0.00	0.00	0.42	0.00	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	118.30	0.58	0.58	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	208.45	0.60	0.90	0.00	1.51	0.00	0.00	0.90	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	179.90	0.83	0.83	0.42	0.83	0.42	0.00	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	111.75	0.92	0.00	0.92	0.00	0.92	0.00	5.54	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	212.28	1.14	0.00	0.00	1.14	1.14	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	218.88	1.38	0.28	0.28	0.00	0.28	0.14	0.83	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	163.26	0.78	0.26	0.52	0.00	0.52	0.00	1.04	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	216.20	1.72	0.43	0.00	0.00	0.00	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	94.01	0.64	0.00	0.00	0.00	0.00	0.00	1.91	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	131.58	0.27	0.80	0.27	0.00	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	240.96	2.39	0.60	0.30	0.30	0.30	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	172.33	1.27	0.57	0.42	0.00	0.00	0.00	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	127.72	0.32	0.32	0.00	0.32	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	216.93	1.77	1.77	0.66	0.22	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	117.17	1.14	0.38	1.14	0.00	0.76	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	161.66	1.42	0.00	0.00	0.28	0.28	0.00	0.28	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	251.46	1.47	0.98	0.74	0.25	1.23	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	103.62	1.96	0.00	0.00	0.00	0.00	0.00	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	145.54	0.88	1.18	0.59	0.00	0.59	0.00	0.88	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	241.33	1.73	0.86	0.86	0.00	0.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	360.63	0.41	1.65	0.41	0.82	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	110.48	1.19	0.30	0.30	0.60	0.60	0.00	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	135.61	0.00	3.77	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	156.84	1.78	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	424.84	3.29	0.99	0.99	2.63	0.00	0.00	2.30	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	249.31	0.00	0.00	0.00	1.05	0.00	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	314.91	2.17	0.40	1.58	0.40	0.40	0.20	0.59	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	416.30	2.79	0.00	2.79	1.86	0.00	0.00	0.93	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	494.57	1.13	4.88	2.63	1.50	0.38	0.00	0.75	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	295.11	1.86	1.07	0.80	1.07	0.00	0.27	0.27	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	295.31	1.36	0.45	0.57	0.34	0.34	0.11	0.23	0.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	339.63	2.21	0.74	2.21	0.00	0.00	0.00	2.95	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	352.13	3.66	4.03	1.83	2.20	0.37	0.00	1.47	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	350.01	9.33	6.22	4.67	7.78	1.56	0.00	6.22	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	371.97	2.67	1.07	0.53	0.00	0.00	0.00	0.53	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	312.98	7.73	0.00	3.86	3.86	0.00	0.00	0.00	11.59
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	379.74	3.03	1.01	1.01	3.03	1.01	0.00	2.02	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	354.60	1.69	1.26	0.42	2.95	0.42	0.00	1.26	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	572.02	5.45	8.17	0.00	2.72	0.00	1.36	2.72	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	258.77	5.72	2.54	1.27	0.64	0.00	0.64	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	283.44	3.24	1.62	0.81	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	694.80	12.08	6.04	6.04	1.51	0.00	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	359.74	17.13	5.71	0.00	5.71	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	486.11	35.89	0.00	3.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	266.14	9.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	276.08	12.55	0.00	0.00	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	642.86	2.80	4.09	1.08	0.86	0.00	0.22	1.29	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	1012.30	5.23	6.27	5.23	1.05	0.52	0.00	1.05	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	542.00	3.34	0.67	2.67	0.00	0.00	0.67	2.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	212.44	1.25	2.50	0.00	0.42	0.42	0.00	1.25	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	298.71	7.61	3.23	1.14	1.52	0.38	0.00	1.14	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	477.16	1.60	1.60	0.00	0.00	0.00	0.00	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	271.30	0.00	1.36	1.36	2.04	0.68	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	560.48	14.70	0.00	1.84	1.84	0.00	0.00	0.00	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	330.64	2.51	6.70	0.84	0.00	0.00	0.00	1.26	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	222.21	2.79	2.56	0.70	0.46	0.00	0.23	1.16	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	509.65	5.67	5.13	3.24	0.54	0.81	0.00	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	433.72	4.41	5.05	1.05	1.05	0.84	0.00	1.05	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	2483.04	11.13	0.00	0.00	11.13	0.00	0.00	11.13	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	455.65	2.98	2.98	1.49	0.00	0.00	0.50	1.49	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	115.58	2.98	7.58	1.89	0.81	0.00	0.27	1.35	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	365.86	4.08	5.89	1.81	2.04	0.00	0.00	1.81	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	396.66	5.39	7.68	3.10	1.31	0.00	0.16	1.80	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	450.35	2.55	3.83	1.09	1.28	0.36	0.00	0.73	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	596.74	5.30	4.77	4.77	2.12	0.00	0.00	2.12	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	546.88	3.60	3.00	3.00	1.20	0.00	0.00	3.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	374.12	13.13	20.35	2.63	2.95	0.33	0.00	2.63	2.30
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	389.81	4.23	7.81	4.07	1.30	0.00	0.49	1.14	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	603.23	3.17	3.88	1.06	1.41	0.18	0.18	1.23	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	400.14	2.11	7.03	3.52	2.81	0.00	0.00	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	238.59	3.22	4.60	1.38	2.30	0.46	0.00	0.46	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	415.18	4.50	3.21	1.93	1.29	0.96	0.00	0.00	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	459.74	18.62	23.45	4.48	6.21	0.00	0.00	4.48	3.10
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	3423.52	60.68	25.28	5.06	0.00	0.00	0.00	2.53	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	460.72	2.23	2.67	1.11	0.67	0.22	0.22	1.78	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	243.87	2.12	4.66	0.85	2.12	0.42	0.00	2.54	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	218.60	5.70	8.07	2.85	1.66	0.24	0.00	0.47	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	405.21	1.29	4.29	1.72	2.15	0.00	0.00	0.43	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	8693.73	63.19	18.06	36.11	18.06	0.00	0.00	0.00	36.11
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	567.81	4.00	6.33	2.33	0.67	0.33	0.00	1.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	397.21	2.71	2.25	0.90	0.90	0.00	0.00	1.80	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	248.79	1.59	3.57	1.98	0.79	0.00	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	470.82	0.93	3.71	0.93	0.00	0.93	0.00	5.57	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	203.94	1.51	3.41	3.78	1.51	0.38	0.00	0.76	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	576.17	2.61	7.50	3.91	2.28	0.33	0.00	1.96	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	686.36	3.05	6.54	3.92	0.44	0.00	0.00	1.74	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	459.07	2.71	2.26	0.00	1.36	0.00	0.00	0.90	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	409.21	0.88	3.53	1.76	1.76	0.00	0.88	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	450.10	3.32	2.66	0.66	0.66	0.00	0.00	2.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	548.13	3.47	2.98	1.49	0.00	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	587.26	4.21	6.51	1.91	1.15	0.00	0.00	2.30	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	143.66	3.02	3.33	1.51	1.81	0.30	0.00	0.60	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	484.26	2.87	3.54	1.55	0.66	0.22	0.00	0.44	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	338.83	2.71	4.07	2.71	1.36	1.36	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	1318.26	5.11	0.00	5.11	0.00	0.00	0.00	0.00	25.55
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	357.88	2.44	1.22	0.61	1.22	0.61	0.00	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	316.94	2.83	2.83	2.20	0.63	0.31	0.00	1.57	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	491.21	6.96	6.66	4.84	0.61	0.61	0.30	2.12	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	370.25	0.00	3.16	1.58	3.16	0.00	0.00	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	336.69	13.60	14.74	6.80	7.94	0.00	0.00	1.13	7.94
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	935.71	15.17	10.12	10.12	0.00	0.00	0.00	10.12	5.06
Myoblast, donor1	11241-116D8	403.62	2.86	1.49	0.99	0.99	0.12	0.50	1.24	1.99
Myoblast, donor2	11322-117D8	534.32	4.41	2.49	1.73	1.15	0.00	0.19	1.73	2.69
Myoblast, donor3	11398-118D3	650.79	5.89	2.69	1.18	1.01	0.17	0.00	1.18	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	4704.58	11.53	8.90	5.11	5.55	0.58	1.02	6.28	7.15
Natural Killer Cells, donor1	11230-116C6	2025.92	15.07	11.99	5.23	2.15	0.31	1.54	3.38	1.23
Natural Killer Cells, donor2	11311-117C6	1386.25	9.05	7.84	3.02	2.11	0.90	2.41	2.41	4.22
Natural Killer Cells, donor3	11387-118C1	1330.53	11.78	8.10	5.52	2.21	0.37	1.84	4.60	4.60
Neural stem cells, donor1	11275-116H6	993.73	11.98	8.71	5.44	0.73	1.45	0.00	0.36	0.00
Neural stem cells, donor2	11352-117H2	1001.33	9.63	3.85	3.85	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	303.82	0.00	0.00	2.28	1.14	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	356.22	2.64	0.22	0.66	0.88	0.22	0.44	0.44	0.44
Neurons, donor3	11655-122E8	560.72	2.47	0.82	0.82	0.00	0.00	0.00	0.82	1.64
Neutrophils, donor1	11233-116C9	1055.14	12.06	6.50	6.50	4.64	1.86	0.00	4.64	0.93
Neutrophils, donor2	11314-117C9	878.36	14.49	5.80	8.70	8.70	2.90	0.00	5.80	0.00
Neutrophils, donor3	11390-118C4	1521.00	14.05	15.27	13.44	2.44	3.05	0.00	4.89	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	1052.47	6.41	2.26	2.37	1.78	0.12	0.00	2.14	1.42
Nucleus Pulposus Cell, donor2	11409-118E5	448.68	1.95	2.60	0.98	0.65	0.33	0.00	0.65	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	509.40	1.40	2.21	0.40	1.00	0.20	0.20	1.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	746.35	2.06	2.48	2.34	1.93	0.41	0.14	0.96	3.03
Olfactory epithelial cells, donor2	11934-125I8	924.63	4.49	1.30	2.75	4.92	0.14	1.30	1.45	6.66
Olfactory epithelial cells, donor3	11935-125I9	807.47	3.06	1.14	1.14	1.14	0.57	0.45	1.48	2.38
Olfactory epithelial cells, donor4	11936-126A1	903.94	5.06	2.14	1.75	1.75	0.88	0.49	1.85	0.88
Oligodendrocyte - precursors, donor1	11496-119F2	829.31	1.81	2.41	0.00	0.60	0.60	0.00	1.20	0.60
Osteoblast - differentiated, donor1	11276-116H7	717.42	4.89	8.08	7.02	1.70	0.00	0.00	0.64	0.43
Osteoblast - differentiated, donor2	11353-117H3	144.03	6.86	3.43	4.57	0.00	0.00	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	379.87	4.97	5.59	8.07	0.62	0.00	0.62	0.62	0.62
Osteoblast, donor1	11277-116H8	547.81	3.32	1.95	1.37	0.98	0.20	0.39	0.20	1.56
Osteoblast, donor2	11354-117H4	696.70	1.40	1.40	0.70	2.11	0.70	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	405.94	3.20	3.20	2.31	0.18	0.00	0.18	0.71	3.38
Pancreatic stromal cells, donor1	11249-116E7	575.58	6.99	6.99	6.32	1.35	0.00	0.34	0.93	1.18
Pericytes, donor1	11491-119E6	577.36	2.23	3.23	1.00	0.56	0.11	0.11	0.11	0.11
Pericytes, donor2	11571-120E5	455.00	5.89	4.75	0.23	0.68	0.00	0.00	0.23	0.45
Pericytes, donor3	11652-122E5	741.57	3.66	2.85	2.03	1.63	0.00	0.00	2.64	1.02
Perineurial Cells, donor1	11499-119F5	1093.93	2.71	1.02	0.45	1.58	0.45	0.23	1.02	1.58
Perineurial Cells, donor2	11579-120F4	1048.00	3.68	3.68	2.02	0.74	0.09	0.00	0.74	1.01
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	2732.23	14.02	9.24	5.42	1.91	0.64	0.32	1.91	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	1588.91	8.82	10.04	6.37	2.20	0.98	0.73	3.92	3.43
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	1782.44	14.37	11.00	7.38	2.07	0.78	0.52	3.49	1.68
Placental Epithelial Cells, donor1	11278-116H9	192.77	2.39	2.39	1.43	0.96	0.00	0.00	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	483.47	2.22	8.87	0.00	5.54	0.00	0.00	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	346.91	2.75	1.77	2.16	0.39	0.00	0.00	1.77	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	220.57	3.80	2.53	0.63	3.48	0.00	0.00	3.16	1.27
Preadipocyte - breast, donor1	11467-119B9	623.17	5.63	10.13	2.81	1.69	0.19	0.00	0.56	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	199.71	0.39	0.13	0.39	0.13	0.52	0.52	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	369.24	6.30	4.50	1.13	1.13	0.45	0.23	0.68	0.90
Preadipocyte - omental, donor1	11468-119C1	599.18	6.71	12.89	3.52	1.39	0.32	0.32	1.39	0.21
Preadipocyte - omental, donor2	11329-117E6	452.62	3.06	2.18	2.62	1.31	0.00	0.00	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	436.34	4.15	7.16	2.44	2.29	0.29	0.14	1.72	0.43
Preadipocyte - perirenal, donor1	11469-119C2	293.31	0.98	1.97	1.97	0.00	0.00	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	228.19	2.46	1.84	1.23	0.00	0.31	0.31	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	428.17	2.48	0.89	0.18	1.24	0.35	0.18	0.71	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	384.67	6.47	3.24	5.28	2.04	0.00	0.17	1.53	0.51
Preadipocyte - visceral, donor1	11280-116I2	877.91	5.31	5.40	4.75	0.56	0.37	0.37	0.19	0.19
Preadipocyte - visceral, donor2	11357-117H7	394.37	5.06	5.98	0.92	1.38	0.00	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	328.94	2.51	2.09	1.25	0.94	0.21	0.00	0.21	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	762.41	17.20	18.71	9.20	1.66	0.75	0.00	3.32	0.75
Prostate Epithelial Cells, donor2	11331-117E8	303.33	5.01	6.50	3.25	0.41	0.14	0.00	1.49	0.27
Prostate Epithelial Cells, donor3	11404-118D9	1019.97	16.60	17.82	13.53	3.00	0.18	0.24	3.06	0.98
Prostate Stromal Cells, donor1	11254-116F3	576.91	4.78	6.61	2.51	1.37	0.11	0.23	1.25	1.25
Prostate Stromal Cells, donor2	11332-117E9	560.13	5.02	3.77	1.79	2.15	0.72	0.00	1.97	2.51
Prostate Stromal Cells, donor3	11405-118E1	543.80	7.82	11.78	5.74	2.29	0.31	0.10	2.29	1.88
Renal Cortical Epithelial Cells, donor1	11516-119H4	670.47	4.38	1.82	2.55	0.73	0.00	0.00	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	667.13	2.98	1.94	0.42	0.90	0.21	0.21	0.28	1.18
Renal Epithelial Cells, donor1	11517-119H5	412.89	1.01	0.51	0.00	1.01	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	414.70	2.13	1.42	0.00	1.42	0.71	0.00	2.13	0.71
Renal Epithelial Cells, donor3	11678-122H4	942.73	3.28	2.01	1.48	1.27	0.32	0.21	0.64	1.48
Renal Glomerular Endothelial Cells, donor1	11514-119H2	385.36	2.04	0.68	0.00	0.00	0.68	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	544.99	1.21	1.08	0.13	0.40	0.81	0.00	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	590.10	3.11	1.11	0.89	1.11	1.11	0.22	0.67	4.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	312.09	2.66	3.99	0.00	0.00	0.67	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	574.65	2.42	1.76	0.88	1.76	0.00	0.00	0.66	0.44
Renal Mesangial Cells, donor2	11598-120H5	527.92	3.76	3.13	1.88	0.63	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	353.14	1.39	2.50	1.66	0.83	0.00	0.00	0.83	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	795.34	1.34	1.07	1.61	1.07	0.00	0.27	0.54	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	386.27	3.37	1.69	0.42	1.69	0.00	0.00	0.84	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	601.49	5.21	1.93	0.77	1.16	0.39	0.39	0.58	1.74
Retinal Pigment Epithelial Cells, donor0	11215-116A9	696.95	1.56	2.59	0.26	1.56	0.52	0.26	0.78	4.15
Retinal Pigment Epithelial Cells, donor1	11528-119I7	1179.33	4.26	5.40	1.42	1.71	0.28	0.00	0.57	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	344.76	0.00	0.00	0.00	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	1128.08	6.27	8.03	4.01	2.01	0.25	0.25	1.51	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	843.64	6.41	10.69	7.88	1.34	0.53	0.40	1.07	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	458.32	1.79	6.25	0.00	0.89	0.89	0.00	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1243.84	3.30	7.71	4.95	3.30	1.10	0.55	0.00	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	1169.97	4.06	4.64	2.90	1.16	1.74	0.58	0.00	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	617.75	2.73	2.34	0.91	0.39	0.39	0.13	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	443.60	2.58	0.50	0.40	0.40	0.40	0.10	0.60	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	570.30	2.57	1.56	1.12	0.22	0.89	0.22	0.45	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	722.06	2.23	1.24	0.74	1.36	0.37	0.37	0.37	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	468.51	3.26	1.40	1.17	0.47	0.23	0.23	0.47	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	573.90	2.08	1.16	1.85	0.92	0.23	1.16	1.39	4.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	571.87	1.92	0.55	0.41	0.41	0.14	0.41	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	378.03	3.78	0.76	0.76	1.36	0.45	0.15	0.45	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	412.32	1.43	1.25	0.18	0.72	0.36	0.54	0.54	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	549.15	1.43	1.00	0.72	1.00	0.57	0.29	0.43	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	447.93	2.68	1.18	0.97	0.32	0.32	0.54	0.54	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	525.07	2.88	1.33	1.11	0.44	0.89	0.00	0.44	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	520.38	3.06	0.76	0.57	0.96	0.38	0.57	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	460.69	2.89	1.02	0.56	0.37	0.65	0.47	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	844.08	3.57	3.57	1.88	0.56	0.19	0.75	0.38	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	617.88	2.12	0.93	0.53	0.53	0.53	0.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	455.85	2.24	1.85	0.19	0.39	0.10	0.68	1.07	1.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	581.09	1.91	1.91	0.19	0.76	0.76	0.38	0.76	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	569.96	2.24	1.92	0.53	0.32	0.00	0.43	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	371.69	2.80	1.40	0.28	2.80	0.56	0.00	1.96	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	495.26	3.76	1.88	0.68	0.51	0.51	0.51	0.34	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	495.57	2.19	1.09	0.55	0.36	0.18	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	461.47	2.94	1.47	1.10	1.35	0.12	0.74	0.37	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	407.12	1.75	2.01	1.75	0.40	0.00	0.81	0.40	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	663.27	1.42	0.47	0.71	1.42	0.24	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	508.93	2.18	2.18	0.79	0.99	0.40	0.20	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	430.74	2.34	1.40	2.10	0.70	0.23	0.70	0.47	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	613.98	1.45	2.49	0.83	0.41	0.00	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	439.32	3.76	0.66	0.66	1.33	0.22	0.22	0.44	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	506.96	2.30	1.25	1.04	0.84	0.84	0.21	1.04	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	654.22	1.48	1.08	0.94	0.40	0.54	0.27	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	470.87	2.04	0.85	0.51	0.17	0.51	0.34	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	605.38	3.86	1.74	0.77	0.58	0.39	0.77	0.39	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	614.85	1.89	0.69	0.52	1.03	0.86	0.52	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	421.25	2.88	2.06	0.96	0.14	0.41	0.55	1.23	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	565.89	4.43	2.46	0.66	0.49	0.82	0.16	0.33	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	555.09	1.36	1.36	0.51	0.68	1.36	0.00	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	454.53	3.40	2.37	1.33	0.30	0.59	0.30	0.30	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	507.25	1.33	1.87	1.87	0.27	0.53	0.00	0.53	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	604.36	3.32	1.52	1.38	0.14	0.41	0.00	0.28	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	364.30	3.57	2.38	1.19	0.71	0.00	0.00	0.48	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	762.03	4.23	3.83	2.62	0.40	0.40	0.20	1.41	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	544.04	2.35	2.64	1.70	0.75	0.28	0.28	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	547.45	5.59	6.64	3.49	0.35	0.00	0.00	0.70	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	509.53	3.93	5.14	1.51	0.91	0.60	0.30	1.21	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	523.94	3.30	5.87	2.45	0.61	0.49	0.61	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	820.92	2.62	4.95	4.51	1.31	0.87	0.58	0.87	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	352.89	6.08	4.26	2.43	0.00	0.00	0.00	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	478.32	3.32	4.52	2.11	0.30	0.30	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	547.15	3.17	13.35	7.92	0.90	0.00	0.23	1.36	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	458.00	3.29	7.49	1.20	0.00	0.60	0.90	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	654.96	6.14	18.07	8.97	1.42	0.35	0.35	0.47	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	431.16	5.76	11.53	5.55	0.21	0.00	0.21	1.71	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	451.33	3.00	3.00	2.40	1.20	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	475.63	2.26	1.88	0.38	0.38	0.56	0.00	0.19	0.94
Schwann Cells, donor2	11578-120F3	398.08	0.00	3.40	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	347.24	1.10	0.22	0.44	0.22	0.00	0.22	0.88	3.51
Sebocyte, donor1	11220-116B5	1369.42	14.24	13.15	3.83	0.00	0.00	0.00	1.10	1.10
Sebocyte, donor2	11301-117B5	924.62	16.54	7.35	3.68	0.92	0.00	0.00	0.92	1.84
Sebocyte, donor3	11378-118B1	593.81	9.28	6.18	5.77	1.03	0.00	0.00	1.24	0.62
Sertoli Cells, donor1	11255-116F4	704.05	11.60	6.63	8.28	1.66	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	768.23	8.47	14.12	5.65	2.82	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	1207.32	10.12	14.96	7.57	1.23	0.09	0.09	0.97	0.35
Skeletal Muscle Cells, donor2	11358-117H8	212.52	2.17	4.34	1.45	0.00	0.00	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	275.06	0.00	3.34	0.84	0.84	1.67	0.00	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	532.55	3.14	0.79	1.41	0.94	0.47	0.16	0.31	1.10
Skeletal Muscle Cells, donor5	11455-119A6	591.75	3.57	1.49	1.19	0.74	0.45	0.00	1.04	0.30
Skeletal Muscle Cells, donor6	11459-119B1	623.15	3.69	1.39	0.92	0.92	0.00	0.46	0.31	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	948.83	6.30	5.17	2.90	1.13	0.00	0.00	1.13	1.39
Skeletal Muscle Satellite Cells, donor2	11321-117D7	590.59	4.85	2.28	1.00	1.43	0.43	0.14	0.57	1.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	565.00	4.27	1.98	1.19	1.39	0.40	0.20	1.49	1.29
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	947.67	3.79	6.57	2.44	1.18	0.25	0.00	1.26	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	281.54	1.45	2.17	0.72	0.00	0.00	0.00	0.00	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	191.95	0.69	1.24	0.69	0.00	0.28	0.14	0.14	0.69
Skin - palm, donor1	10286-104F7	429.78	0.00	2.69	0.00	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	244.78	4.04	3.60	1.59	2.45	0.14	0.29	1.59	1.73
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	238.82	1.64	0.82	0.00	1.64	0.00	2.45	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	307.17	3.76	2.73	0.65	1.95	0.00	0.00	1.95	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	757.59	9.87	11.68	7.37	2.36	0.28	0.28	2.09	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	765.74	12.80	10.83	5.20	1.97	0.28	0.14	2.95	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	705.81	1.48	1.27	0.63	0.63	0.85	1.48	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	1013.48	15.21	14.62	7.64	1.50	0.07	0.75	3.67	1.20
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	727.64	4.63	5.55	1.85	3.39	0.00	0.31	1.23	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	399.97	2.00	2.00	1.56	0.67	0.00	0.44	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	305.67	1.76	2.94	1.76	0.59	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	1015.68	5.75	3.31	1.10	0.66	0.00	0.00	0.66	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	538.30	2.36	3.54	4.73	0.79	0.79	0.00	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	343.79	0.00	1.55	3.86	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	606.46	1.00	1.00	1.00	1.00	0.00	0.00	0.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	617.61	7.45	6.12	5.06	0.80	0.27	0.27	0.93	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	555.24	4.65	3.55	1.33	1.99	0.22	0.22	0.66	2.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	180.39	1.66	1.54	0.90	0.13	0.26	0.13	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	409.59	1.63	0.65	0.33	0.00	0.33	0.00	0.65	1.30
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	446.83	3.54	2.36	1.48	0.89	0.00	0.00	0.30	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	348.08	2.70	1.42	0.85	1.14	0.14	0.00	0.85	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	402.46	1.30	0.65	0.81	0.98	0.00	0.33	0.33	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	803.09	2.13	2.74	1.52	1.22	0.30	0.00	2.44	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	587.46	4.04	4.55	2.27	0.00	0.76	0.00	0.51	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	2729.84	18.36	0.00	0.00	0.00	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	233.65	3.34	2.38	0.95	0.48	0.00	0.00	0.95	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	380.48	2.36	1.62	1.18	0.88	0.29	0.00	0.74	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	374.73	2.58	1.72	0.65	1.51	0.43	0.00	0.43	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	395.59	2.94	1.26	0.52	1.05	0.10	0.31	0.52	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	602.01	6.50	2.78	5.57	0.31	0.00	0.00	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	225.28	2.16	0.00	1.08	1.08	0.00	1.08	0.00	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	289.59	2.39	1.79	0.90	0.30	0.00	0.30	0.30	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	428.11	0.68	0.68	0.00	0.68	0.00	0.00	1.02	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	1255.37	4.63	3.93	1.57	1.88	0.08	0.16	1.33	2.83
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	919.56	25.76	23.85	11.98	1.81	0.20	0.00	2.82	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	345.43	1.82	2.73	0.91	1.59	0.00	0.23	0.23	2.73
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	361.68	4.23	1.81	1.21	1.81	0.00	0.60	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	1216.80	4.24	0.79	1.85	2.65	0.26	0.53	1.06	1.85
Smooth Muscle Cells - Prostate, donor1	11257-116F6	957.41	3.86	9.05	3.60	0.67	0.27	0.13	0.53	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	685.45	9.27	9.14	6.01	2.25	0.00	0.25	2.00	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	480.44	7.86	5.58	5.07	0.76	0.25	0.00	2.28	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	672.75	7.39	4.82	3.92	0.75	0.45	0.00	0.75	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	317.32	3.75	2.25	0.00	0.75	0.75	0.75	1.50	3.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	4521.46	29.72	25.84	3.88	2.58	0.00	0.00	6.46	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	375.31	4.65	2.79	1.40	0.00	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	380.68	2.52	5.05	2.52	0.00	0.00	0.00	3.53	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	344.42	4.39	7.83	3.45	1.25	0.00	0.00	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	441.32	2.06	2.36	0.29	1.18	0.29	0.00	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	781.92	0.92	0.83	0.08	0.50	0.42	0.25	0.17	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	542.37	3.27	2.80	0.47	0.47	0.00	0.93	0.93	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	455.50	3.45	2.73	3.31	0.14	0.14	0.00	0.43	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	355.66	2.80	3.31	1.53	1.27	0.00	0.00	0.25	2.80
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	337.14	2.07	1.69	1.13	0.38	0.38	0.19	0.19	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	1022.93	2.52	0.84	0.70	1.12	0.28	0.14	0.70	1.12
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	834.11	1.42	0.75	1.17	0.92	0.17	0.00	0.34	0.84
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	208.09	0.95	0.00	1.43	0.48	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	412.01	4.16	4.65	3.43	1.47	0.24	0.24	0.49	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	946.10	5.30	12.81	5.74	3.09	0.22	0.00	0.66	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	172.91	1.76	0.59	0.88	0.00	0.00	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	456.94	3.89	6.03	2.14	0.39	0.19	0.19	0.58	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	351.99	2.12	1.59	1.32	3.97	0.53	0.26	0.79	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	621.90	2.60	7.44	2.60	3.35	0.37	0.00	0.74	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	523.55	2.52	3.59	0.72	2.52	0.00	0.00	2.16	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	239.04	1.99	1.42	1.14	1.14	0.00	0.00	0.57	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	629.40	0.79	1.18	1.18	0.79	0.00	1.58	0.00	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	402.51	6.09	4.32	1.78	2.03	0.25	0.25	2.79	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	626.13	7.19	11.18	3.59	0.80	0.00	0.00	2.80	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	393.34	4.18	4.60	3.34	3.76	0.84	0.00	2.93	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	330.48	1.38	2.29	1.38	2.29	0.46	0.00	0.92	0.00
Synoviocyte, donor1	11291-117A4	602.42	4.21	6.73	1.51	1.85	0.00	0.00	0.67	0.34
Synoviocyte, donor2	11368-117I9	565.73	5.87	9.89	2.35	1.84	0.00	0.17	1.84	2.35
Synoviocyte, donor3	11440-118H9	676.04	4.92	4.69	2.90	2.23	0.00	0.00	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	660.35	2.50	1.43	0.00	1.79	0.00	0.36	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	362.71	3.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	407.06	1.39	3.01	0.23	0.00	0.46	0.23	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	845.95	3.94	3.94	5.16	0.72	0.29	0.22	0.50	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	305.38	3.09	1.93	1.55	0.39	0.00	0.39	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	321.84	2.29	4.01	0.57	0.00	0.00	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	874.09	7.14	10.95	8.86	1.23	0.98	0.49	1.48	0.49
Urethra, donor2	10319-105A4	1104.23	7.19	7.19	3.60	0.00	7.19	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	590.56	2.66	2.66	0.80	0.80	0.27	0.00	0.53	1.06
Urothelial Cells, donor2	11600-120H7	539.56	2.80	4.41	2.00	2.00	0.00	0.00	0.80	1.60
Urothelial Cells, donor3	11681-122H7	518.23	3.21	2.52	1.15	2.06	0.00	0.00	0.46	0.92
Urothelial cells, donor0	11216-116B1	978.51	3.57	2.23	0.89	0.45	0.45	0.00	1.11	1.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	1202.99	8.01	2.67	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	1312.38	4.29	1.43	0.00	5.72	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	909.04	3.42	0.68	0.68	2.74	0.00	0.00	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	1082.94	7.23	1.38	0.69	1.72	0.00	1.03	1.03	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	964.51	6.97	0.58	0.58	4.65	0.58	1.74	3.49	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	1168.27	4.16	0.00	0.00	2.08	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	1133.47	3.67	0.00	1.84	2.75	0.92	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	733.97	2.74	2.74	3.65	1.83	0.00	0.00	1.83	1.83
Wilms' tumor cell line:G-401	10809-111A8	1895.32	10.12	8.02	3.70	4.19	0.86	1.48	3.08	2.71
Wilms' tumor cell line:HFWT	10597-108E3	429.46	1.76	0.88	0.88	0.00	0.00	1.76	1.76	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	1500.50	5.59	3.35	0.84	3.63	0.84	0.56	1.40	1.12
achilles tendon, donor2	10292-104G4	828.68	6.20	2.07	0.00	0.00	2.07	0.00	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	2566.13	8.41	4.59	2.55	6.37	0.51	0.76	6.88	3.57
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1961.64	4.18	1.86	1.63	2.32	0.93	1.16	1.16	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	1679.96	7.83	3.80	1.54	1.90	1.42	0.36	1.31	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	1113.22	3.27	0.82	1.36	0.82	1.36	0.82	2.72	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	2535.66	13.77	5.62	3.65	8.15	0.28	1.97	5.34	7.87
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	529.55	4.02	1.27	0.21	0.85	0.00	0.85	0.21	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	2070.44	13.34	5.17	1.36	4.08	0.00	0.54	2.18	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	1617.14	8.81	4.41	2.64	7.05	0.00	0.00	3.53	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	1316.14	7.35	2.45	3.27	4.49	0.00	0.82	1.23	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	2974.75	8.54	5.82	2.33	7.38	1.16	1.94	6.60	4.66
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	638.11	5.15	2.39	0.74	1.10	0.37	0.37	0.74	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	1322.28	7.80	3.90	0.00	0.00	0.00	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	1911.34	8.83	4.18	2.09	3.95	0.70	0.93	1.86	3.02
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	3536.85	16.31	6.21	4.92	7.51	0.78	2.07	5.95	6.73
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	2807.88	14.90	4.38	1.75	8.77	0.00	1.17	3.21	4.68
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	1555.09	2.79	1.86	1.86	2.79	0.46	0.93	2.79	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	862.81	4.94	4.52	0.41	2.88	0.00	0.41	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	662.71	8.29	5.83	1.23	1.84	0.61	0.31	4.30	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	1647.10	10.67	1.28	2.13	1.71	0.00	0.85	2.56	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1803.38	9.10	1.82	1.52	0.91	0.61	0.61	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	2041.91	7.70	4.09	1.68	1.20	0.72	2.65	0.96	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1425.30	5.12	1.78	1.34	3.56	0.67	0.89	2.00	2.23
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	664.43	1.67	0.67	0.00	1.33	2.00	0.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1289.59	3.72	0.00	0.00	3.72	9.29	0.00	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1833.96	6.40	7.16	3.01	3.01	1.13	0.75	2.26	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	863.11	2.62	2.18	1.31	0.44	1.74	1.74	2.62	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1272.76	1.87	0.00	1.87	1.87	1.87	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	1762.24	4.47	4.47	2.12	2.35	0.71	1.18	2.83	1.18
adipose tissue, adult, pool1	10010-101C1	769.70	6.98	11.01	6.05	1.55	0.93	0.16	0.31	0.47
adipose, donor1	10184-103D4	585.24	24.63	41.64	13.49	5.86	2.93	1.17	2.35	8.80
adipose, donor2	10185-103D5	325.23	6.49	18.25	7.70	2.03	0.00	0.81	2.84	0.41
adipose, donor3	10186-103D6	680.45	10.62	10.35	6.53	1.36	0.54	1.09	3.81	2.72
adipose, donor4	10187-103D7	1786.38	13.87	8.67	6.07	5.20	0.00	2.60	4.33	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	1585.46	5.37	2.05	1.10	0.47	3.47	0.63	2.53	0.47
adrenal gland, adult, pool1	10081-102A9	294.65	10.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	1229.20	5.47	4.14	5.47	1.07	0.93	0.53	1.07	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	2850.18	7.15	7.15	2.86	2.14	1.79	2.14	1.43	3.93
amniotic membrane cells, donor1	12235-129G3	766.49	4.64	2.78	2.09	2.78	1.16	0.46	2.32	0.93
amniotic membrane cells, donor2	12236-129G4	551.78	2.37	4.73	3.72	0.00	0.68	0.00	0.68	1.69
amniotic membrane cells, donor3	12237-129G5	1582.89	6.78	4.42	1.47	4.12	2.65	0.29	0.00	1.18
amygdala - adult, donor10196	10167-103B5	301.19	0.00	2.37	1.19	2.37	2.37	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	489.28	1.62	0.61	0.61	0.20	1.62	0.81	1.22	0.00
amygdala, newborn, donor10223	10360-105E9	259.83	2.58	1.61	0.65	0.00	1.94	0.00	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	1164.18	9.55	11.33	5.09	1.66	0.00	0.38	1.91	1.15
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	1852.57	8.82	6.84	3.09	5.52	0.00	1.32	4.41	1.54
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1343.16	3.34	3.34	1.67	3.34	2.00	1.00	2.00	2.67
aorta, adult, pool1	10052-101G7	632.33	2.94	1.37	1.37	0.59	0.00	0.00	1.37	0.78
appendix, adult	10189-103D9	822.81	14.36	14.36	11.64	1.55	0.78	0.39	2.33	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1332.06	2.75	4.47	3.10	2.41	1.03	2.41	1.38	2.06
artery, adult	10190-103E1	187.50	4.08	1.36	1.36	0.00	1.36	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	676.24	3.04	1.74	1.16	0.87	0.14	0.29	0.29	0.29
b cell line:RPMI1788	10427-106D4	2121.22	9.96	5.20	6.25	2.83	0.89	0.74	2.08	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	358.46	1.66	0.83	1.94	1.11	0.28	0.00	0.55	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	2345.44	15.48	10.02	5.85	2.18	0.79	0.89	1.69	0.99
bile duct carcinoma cell line:TFK-1	10496-107C1	1047.45	2.01	3.68	0.84	1.17	0.00	0.33	1.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	2207.31	7.27	7.83	8.39	2.80	0.00	3.91	5.59	5.59
bladder, adult, pool1	10011-101C2	1208.74	11.95	10.43	7.82	1.85	1.96	0.11	2.61	0.76
blood, adult, pool1	10053-101G8	1078.52	4.43	11.07	15.50	0.00	0.00	0.00	4.43	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	450.44	1.71	0.00	0.00	0.86	0.00	0.00	0.00	0.86
bone marrow, adult	10192-103E3	821.94	5.40	4.72	3.37	2.02	0.00	0.00	2.02	1.35
brain, adult, donor1	10084-102B3	177.34	1.03	2.05	3.08	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	284.52	1.89	1.45	1.89	0.00	1.45	0.11	0.22	0.22
brain, fetal, pool1	10085-102B4	675.86	0.00	2.67	5.34	0.00	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	2002.34	9.25	8.92	1.98	5.62	1.65	0.99	13.21	2.64
breast carcinoma cell line:MDA-MB-453	10419-106C5	1962.71	4.49	3.12	1.25	1.62	0.62	1.37	1.00	0.12
breast, adult, donor1	10080-102A8	543.60	4.42	5.05	5.68	0.63	0.00	0.63	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	1930.59	4.45	2.54	1.14	2.54	0.25	0.64	1.02	2.16
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	1632.99	7.42	2.16	2.16	1.24	1.86	0.62	1.86	2.16
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	848.36	3.68	0.92	1.84	3.68	0.92	0.23	0.92	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	310.11	0.73	1.21	0.73	1.21	0.48	0.24	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	653.53	1.41	2.35	1.88	1.41	2.35	0.47	1.41	0.47
carcinoid cell line:NCI-H727	10735-110B6	1086.26	2.84	1.75	0.77	1.86	0.98	0.22	1.31	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	1273.29	2.22	2.54	0.95	1.90	0.95	0.32	1.90	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	1122.74	4.79	5.06	1.86	2.40	0.80	0.00	0.80	2.13
caudate nucleus - adult, donor10196	10177-103C6	583.72	4.61	3.45	0.00	1.15	1.15	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	469.02	3.18	1.17	1.34	0.50	1.34	0.67	0.17	1.51
caudate nucleus, adult, donor10258	10379-105H1	295.72	3.06	1.53	0.76	0.00	0.76	1.53	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	391.87	3.30	2.20	0.73	0.37	1.83	1.10	0.73	0.37
cerebellum - adult, donor10196	10173-103C2	824.46	0.00	0.00	2.91	0.00	2.91	0.00	5.83	5.83
cerebellum, adult, donor10252	10166-103B4	699.03	3.20	1.71	2.14	0.64	2.14	0.43	0.21	0.21
cerebellum, adult, pool1	10083-102B2	288.72	0.69	2.76	1.03	0.69	0.00	0.34	0.00	1.38
cerebellum, newborn, donor10223	10357-105E6	392.73	3.32	4.15	0.83	0.00	1.66	0.83	1.66	0.83
cerebral meninges, adult	10188-103D8	127.58	1.26	2.02	1.26	0.00	0.00	0.25	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	404.91	5.12	3.65	1.46	0.00	0.00	0.73	2.92	0.73
cervical cancer cell line:D98-AH2	10552-107I3	1335.45	3.59	6.47	3.74	1.01	0.14	1.29	0.72	0.58
cervical cancer cell line:ME-180	10553-107I4	842.50	2.82	2.82	0.50	0.33	0.17	0.17	1.16	0.33
cervix, adult, pool1	10013-101C4	1109.01	13.86	10.08	8.92	1.26	0.63	0.10	2.20	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	514.86	2.09	2.79	1.53	1.25	0.70	0.42	1.25	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	390.57	1.31	0.00	1.31	0.00	1.31	1.31	1.31	2.61
choriocarcinoma cell line:BeWo	10423-106C9	1468.07	25.35	25.60	14.17	2.36	1.49	0.62	3.11	0.87
choriocarcinoma cell line:SCH	10785-110H2	1438.13	5.42	2.59	2.09	3.45	1.23	0.49	2.09	1.72
choriocarcinoma cell line:T3M-3	10618-108G6	862.85	4.98	5.93	2.37	0.95	1.66	0.00	1.42	0.47
chorionic membrane cells, donor1	12238-129G6	592.63	3.70	3.42	1.42	1.14	0.00	0.00	1.14	7.69
chorionic membrane cells, donor2	12239-129G7	435.81	6.56	9.25	5.57	0.50	0.30	0.00	1.49	0.30
chorionic membrane cells, donor3	12240-129G8	1608.89	8.79	13.74	11.54	6.59	0.55	0.00	2.20	4.40
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	728.07	6.06	3.03	3.03	3.03	3.03	1.01	4.04	13.13
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	3269.33	9.99	7.11	3.27	5.57	0.77	0.77	3.84	2.31
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	2602.45	5.91	5.91	3.17	3.17	1.06	1.06	6.34	2.32
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1283.23	3.60	2.05	1.03	1.54	1.28	0.77	1.54	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1583.09	4.11	1.45	0.73	1.45	1.94	0.24	0.97	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1606.28	5.50	2.85	1.22	1.83	1.63	1.43	1.22	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	1100.09	2.06	1.77	0.29	2.06	2.65	1.47	1.77	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	4614.37	19.55	8.34	3.91	2.61	2.61	1.82	3.13	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	825.87	6.86	6.40	1.37	3.20	1.83	0.00	0.91	2.51
clear cell carcinoma cell line:TEN	10636-108I6	1264.17	6.07	2.43	2.26	3.30	0.00	1.21	1.39	1.39
colon carcinoma cell line:CACO-2	10513-107D9	753.95	3.29	1.83	0.18	0.73	0.37	0.73	0.37	0.55
colon carcinoma cell line:COLO-320	10420-106C6	2061.56	6.46	3.42	1.52	1.14	0.00	1.52	1.14	0.38
colon, adult, donor1	10082-102B1	610.49	4.76	3.57	2.38	0.00	0.00	0.00	1.19	3.57
colon, adult, pool1	10014-101C5	965.17	18.33	12.10	8.93	0.94	0.47	0.24	2.23	0.71
colon, fetal, donor1	10070-101I7	954.17	8.65	22.25	4.94	1.85	1.85	0.00	1.85	1.85
common myeloid progenitor CMP, donor1	12130-128D6	330.01	4.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	325.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	2043.08	38.67	8.92	1.70	2.55	0.00	0.85	3.40	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	2348.65	21.43	14.94	4.68	3.02	1.21	1.06	2.87	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	2590.80	14.10	4.09	2.68	3.10	1.27	0.28	1.83	0.99
corpus callosum, adult, pool1	10042-101F6	649.89	2.99	1.55	1.22	0.55	1.00	0.22	0.11	0.77
cruciate ligament, donor2	10295-104G7	781.29	3.24	0.81	0.81	0.00	1.62	0.00	5.67	0.00
diaphragm, fetal, donor1	10069-101I6	297.75	0.80	0.80	3.21	0.80	0.00	0.00	1.61	1.61
diencephalon, adult	10193-103E4	205.67	1.68	1.92	2.64	0.24	0.48	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	1785.46	10.10	6.66	2.53	7.35	0.46	1.15	1.61	7.12
ductal cell carcinoma cell line:KLM-1	10438-106E6	2334.63	6.67	7.18	2.56	5.13	1.03	0.26	1.28	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	1206.50	7.22	8.67	3.13	4.09	0.48	0.48	1.20	1.44
ductus deferens, adult	10196-103E7	665.28	5.98	2.49	2.49	0.50	2.49	0.50	0.50	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	1038.41	4.32	2.88	5.76	1.44	0.00	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	974.00	9.56	4.41	0.74	2.94	2.94	0.00	2.21	1.47
dura mater, adult, donor1	10041-101F5	1155.23	7.02	5.86	3.72	0.41	0.66	0.08	0.91	0.50
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	678.88	13.55	17.32	6.88	1.11	0.44	2.44	1.55	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	723.92	3.73	5.30	1.72	1.72	2.72	0.86	0.72	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	728.84	4.93	5.55	0.62	0.00	1.23	0.00	2.47	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	768.58	3.33	2.72	1.21	2.12	0.00	0.91	0.61	2.72
embryonic pancreas cell line:1C3IKEI	10606-108F3	895.07	3.70	3.40	1.85	0.93	0.62	0.93	1.54	2.47
embryonic pancreas cell line:2C6	10603-108E9	865.57	0.00	1.31	1.31	0.00	0.00	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	966.03	4.69	3.35	1.34	2.01	0.00	1.34	2.68	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	995.53	3.08	3.62	1.45	3.99	0.72	0.36	3.08	1.45
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	691.34	6.27	2.09	0.48	2.25	0.32	0.16	1.29	1.77
epidermoid carcinoma cell line:A431	10426-106D3	2028.31	9.23	8.89	5.67	1.22	0.89	0.11	2.22	1.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	2922.97	11.77	5.50	3.41	2.20	2.20	1.54	1.98	1.43
epididymis, adult	10197-103E8	524.32	13.40	25.75	5.86	0.42	2.09	0.84	1.05	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	913.66	3.37	3.02	1.42	3.55	1.24	1.06	3.02	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	1941.83	10.62	7.47	5.11	2.36	0.79	1.18	3.54	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	1455.96	4.98	2.23	1.83	1.97	1.05	1.97	1.31	5.24
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	1525.22	5.61	3.05	1.77	1.97	1.48	1.48	1.77	2.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	1196.92	5.94	4.15	1.23	2.24	1.12	2.02	1.34	3.47
esophagus, adult, pool1	10015-101C6	1395.39	18.47	14.02	9.56	2.34	1.06	0.11	2.34	1.70
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	1935.15	10.39	15.65	5.13	1.00	0.25	0.75	2.00	0.75
eye - muscle inferior rectus, donor1	10272-104E2	255.94	7.24	4.83	2.41	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	404.01	4.21	2.10	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	62.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	252.23	1.15	1.15	0.00	1.15	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	598.99	8.74	1.46	0.00	0.00	0.00	0.00	4.37	1.46
eye, fetal, donor1	10054-101G9	686.69	4.83	1.78	0.76	1.27	1.53	0.00	1.02	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	1226.98	3.72	3.72	2.18	1.80	0.26	0.51	1.92	1.54
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	959.41	4.99	3.32	1.42	0.71	1.19	1.19	2.37	2.37
frontal lobe, adult, pool1	10040-101F4	368.73	0.94	1.13	0.84	0.19	1.78	0.56	0.00	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	925.37	1.80	5.10	0.90	1.80	1.20	0.90	3.00	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	1275.63	4.21	2.10	1.46	0.37	0.73	1.10	0.27	0.73
gall bladder, adult	10198-103E9	597.55	7.73	13.28	3.86	0.48	0.24	0.48	1.69	0.97
gamma delta positive T cells, donor1	11937-126A2	866.48	3.76	3.76	2.15	2.15	0.00	1.61	1.07	1.61
gamma delta positive T cells, donor2	11938-126A3	664.81	5.23	3.73	2.24	1.87	0.37	0.37	2.61	2.24
gastric adenocarcinoma cell line:MKN1	10614-108G2	607.88	4.01	2.96	2.11	1.06	0.42	0.63	1.06	3.17
gastric adenocarcinoma cell line:MKN45	10612-108F9	1866.46	7.74	5.80	3.87	3.09	0.19	0.19	3.67	6.96
gastric cancer cell line:AZ521	10549-107H9	1215.56	2.62	2.79	0.33	1.64	2.30	1.31	0.82	0.82
gastric cancer cell line:GSS	10560-108A2	1013.15	5.49	6.41	4.58	2.75	2.75	0.00	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	1272.05	7.77	6.85	3.20	2.06	4.34	0.46	1.83	2.97
giant cell carcinoma cell line:LU65	10487-107B1	656.09	2.18	1.72	0.69	1.61	0.11	1.03	0.80	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	2510.17	13.16	10.92	5.74	1.40	0.84	0.84	2.24	1.40
glassy cell carcinoma cell line:HOKUG	10688-109F4	783.92	2.49	2.24	1.50	1.50	0.50	0.25	4.24	1.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	238.34	0.95	0.53	0.74	0.42	1.58	1.06	0.42	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	251.53	0.70	0.56	0.56	0.14	1.83	1.40	0.42	0.00
glioblastoma cell line:T98G	10485-107A8	934.31	2.76	1.43	0.99	1.43	0.66	0.44	0.99	0.55
glioma cell line:GI-1	10413-106B8	2139.47	17.87	16.11	11.42	2.64	1.76	0.29	2.64	0.88
globus pallidus - adult, donor10196	10175-103C4	369.56	1.46	4.37	1.46	1.46	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	714.95	1.71	1.71	0.98	0.24	2.20	0.24	0.24	0.98
globus pallidus, adult, donor10258	10367-105F7	98.58	2.74	0.00	0.00	0.00	0.00	0.00	0.00	2.74
globus pallidus, newborn, donor10223	10364-105F4	260.60	4.80	4.26	1.60	0.53	1.60	0.53	1.07	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	327.92	7.34	0.00	2.45	0.00	0.00	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	251.35	10.93	0.00	0.00	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	193.38	0.00	0.00	0.00	10.45	0.00	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	354.23	0.64	0.96	0.64	1.28	0.32	0.64	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	1157.89	4.59	3.67	0.92	1.84	0.46	1.38	1.38	0.00
hIPS +CCl2, biol_rep2	14384-156C1	961.62	2.29	0.91	0.46	4.57	3.66	2.29	2.29	0.00
hIPS +CCl2, biol_rep3	14385-156C2	1063.40	1.29	4.51	0.64	4.51	0.64	1.29	1.29	0.00
hIPS, biol_rep1	14380-156B6	484.37	2.87	2.87	0.00	1.44	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	952.67	0.69	2.06	0.00	3.43	0.00	0.69	1.37	0.00
hIPS, biol_rep3	14382-156B8	348.70	1.10	2.21	0.00	1.10	3.31	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	1768.31	8.62	4.02	1.72	3.16	0.29	0.57	1.72	4.88
heart - mitral valve, adult	10205-103F7	276.55	2.99	0.90	2.69	1.20	1.79	0.00	1.49	0.00
heart - pulmonic valve, adult	10206-103F8	342.79	1.05	2.61	0.78	0.78	1.05	0.00	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	390.51	3.33	4.16	5.83	0.00	0.83	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	1990.16	11.63	9.39	4.08	5.92	2.86	0.20	5.71	6.12
heart, adult, diseased, donor1	10051-101G6	173.74	0.85	0.85	0.00	0.00	0.85	0.00	0.00	1.28
heart, adult, pool1	10016-101C7	212.27	1.38	0.23	0.23	0.69	0.69	0.00	0.46	0.23
heart, fetal, pool1	10046-101G1	793.10	2.26	1.44	0.92	0.82	0.82	0.00	0.72	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	702.51	2.16	0.62	0.93	0.93	0.62	0.00	0.62	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	2893.27	16.65	15.46	5.95	2.38	1.19	3.57	14.27	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	1212.14	4.53	2.43	1.66	1.10	0.99	0.88	0.88	2.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	1113.61	5.34	3.16	1.70	1.82	0.73	0.73	1.09	3.64
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	1300.86	5.86	2.83	1.21	1.01	0.81	1.01	1.41	1.62
hepatoma cell line:Li-7	10484-107A7	896.96	3.56	3.78	1.22	1.33	0.33	0.78	0.67	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	1461.07	3.52	2.21	1.61	2.81	0.10	0.70	1.31	1.41
hippocampus - adult, donor10196	10169-103B7	335.95	0.95	0.00	0.00	0.95	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	530.25	1.84	1.63	1.22	1.22	2.86	1.02	1.22	1.02
hippocampus, adult, donor10258	10374-105G5	198.68	0.50	0.00	0.00	0.50	0.50	0.50	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	203.73	3.17	2.82	1.76	0.35	0.70	0.70	1.06	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	575.55	10.99	17.70	3.05	3.66	1.83	0.61	1.83	16.48
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	799.95	8.64	10.80	6.28	1.77	2.55	0.98	2.75	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	907.68	11.93	9.65	3.55	2.29	1.52	0.76	1.02	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	833.39	19.74	37.22	10.15	3.38	3.38	0.00	5.64	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1150.59	30.21	46.48	21.95	9.04	3.36	1.81	11.10	10.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	882.21	16.70	29.61	12.15	4.56	2.28	0.00	5.69	5.31
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	465.67	11.68	14.01	8.17	1.46	1.17	0.58	2.63	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	696.27	14.22	19.17	10.56	2.37	1.51	0.22	7.11	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	507.16	9.59	10.01	5.42	2.50	1.25	1.25	5.00	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	506.97	4.26	7.58	5.92	0.24	0.24	0.24	1.66	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	640.62	7.39	9.80	6.91	1.93	0.16	0.32	3.70	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	482.76	5.39	6.73	4.71	1.35	0.00	0.00	0.00	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	995.87	14.08	13.30	7.04	2.97	2.50	1.56	2.35	2.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	1047.44	8.35	9.83	2.95	5.90	1.47	2.46	2.95	8.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	703.44	15.71	15.71	6.11	2.62	0.87	0.87	1.75	6.98
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	947.49	21.00	40.28	16.04	4.39	2.29	0.76	6.30	2.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	905.72	13.52	28.78	6.98	1.74	1.31	0.00	8.29	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	507.26	19.99	31.48	10.00	3.50	2.50	1.50	7.00	6.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	503.76	9.42	14.32	8.10	3.20	0.94	0.00	6.97	2.07
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	575.67	10.00	10.00	7.73	2.73	1.36	0.00	6.37	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	435.40	7.20	8.14	3.13	3.13	0.63	0.00	2.51	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	393.88	4.74	6.04	2.94	2.29	0.00	0.65	1.96	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	403.24	3.77	6.68	4.35	1.74	0.58	0.58	2.90	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	396.67	5.08	9.27	2.69	2.09	0.60	0.30	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	798.47	9.61	9.98	7.39	2.96	3.14	2.77	3.51	4.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	874.40	8.27	9.70	3.71	2.85	0.86	2.28	2.57	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	556.12	9.80	14.70	3.27	3.27	2.04	1.22	0.41	5.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	830.56	14.79	22.53	11.62	4.22	1.76	1.06	5.63	7.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	740.54	19.00	19.64	8.55	1.58	1.27	0.32	5.38	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	681.80	13.32	22.39	7.57	3.63	0.30	0.91	2.42	2.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	403.87	5.69	7.24	3.62	1.55	0.52	0.00	3.10	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	359.98	1.99	5.31	3.98	3.32	0.00	0.00	3.32	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	297.32	3.85	3.33	3.59	1.80	0.26	0.26	1.03	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	382.19	5.62	5.37	3.58	1.79	0.26	0.26	1.79	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	381.64	1.51	3.03	1.51	1.51	0.00	0.00	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	395.20	4.37	6.05	4.70	0.34	0.67	0.34	2.69	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1060.94	10.63	17.15	5.31	2.90	3.14	1.93	2.90	5.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	1120.83	17.83	12.03	5.79	1.78	3.12	2.23	3.12	4.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	1050.74	16.10	15.61	8.29	4.88	2.93	2.93	3.90	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	953.22	22.92	25.37	16.50	4.58	1.53	0.92	3.97	2.75
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	953.20	29.28	74.82	45.55	29.28	0.00	0.00	0.00	39.04
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	749.92	17.87	38.72	14.89	2.98	2.98	1.32	3.64	6.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	608.60	5.47	12.59	6.02	3.83	0.55	0.55	3.28	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	606.16	6.51	14.84	5.43	1.81	0.72	0.00	3.62	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	509.25	11.74	11.03	6.76	2.14	0.00	0.36	2.85	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	477.35	3.58	3.58	1.19	4.77	0.00	0.00	2.39	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	935.79	15.44	26.00	13.68	2.98	0.81	0.41	3.25	1.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	501.88	5.93	7.27	4.58	1.35	0.54	0.54	1.62	0.81
immature langerhans cells, donor1	11904-125F5	731.04	8.96	4.12	1.45	1.45	0.24	0.73	0.97	0.73
immature langerhans cells, donor2	11905-125F6	632.91	6.34	2.38	0.00	0.00	0.79	0.00	2.38	0.79
insula, adult, pool1	10039-101F3	369.45	1.51	0.76	1.42	0.19	1.70	0.85	0.09	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	810.59	4.88	4.23	3.90	2.93	0.00	0.65	1.63	0.33
kidney, adult, pool1	10017-101C8	481.71	4.51	2.70	1.30	1.00	0.40	0.20	0.10	0.60
kidney, fetal, pool1	10045-101F9	836.17	3.32	1.56	1.41	0.42	0.64	0.00	0.35	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	3360.78	15.62	12.92	5.68	2.56	1.42	1.70	2.98	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	355.01	2.63	2.90	1.66	0.97	0.00	0.28	1.11	1.52
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	1734.07	3.85	2.39	1.10	1.10	0.92	0.92	2.39	2.02
left atrium, adult, donor1	10079-102A7	293.67	4.36	5.99	3.81	1.63	0.54	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	202.77	1.01	2.53	3.03	1.01	0.00	0.00	0.51	1.01
leiomyoblastoma cell line:G-402	10721-110A1	1177.34	1.64	2.19	1.09	0.27	0.82	0.82	1.09	0.82
leiomyoma cell line:10964C	10569-108B2	453.01	6.11	6.47	3.23	1.80	0.72	0.00	1.44	1.44
leiomyoma cell line:15242A	10570-108B3	265.76	3.26	2.17	1.09	0.54	0.54	0.00	1.09	1.63
leiomyoma cell line:15425	10571-108B4	362.04	3.40	3.40	1.21	1.70	0.00	0.24	1.46	2.19
leiomyosarcoma cell line:Hs 5.T	10722-110A2	158.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	445.41	4.18	3.14	2.09	0.00	0.00	3.14	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	2215.83	8.50	4.96	2.13	3.19	0.83	0.71	2.36	2.13
liposarcoma cell line:KMLS-1	10782-110G8	894.15	4.69	3.28	1.72	1.25	0.16	0.16	0.62	0.62
liposarcoma cell line:SW 872	10726-110A6	730.67	2.68	2.68	1.10	1.22	1.10	0.37	1.10	0.97
liver, adult, pool1	10018-101C9	690.38	6.81	9.40	8.43	0.32	0.32	0.00	0.81	0.65
liver, fetal, pool1	10086-102B5	422.38	1.88	0.94	3.76	1.88	0.00	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	298.79	1.02	0.73	1.02	0.15	1.31	0.29	0.29	0.44
locus coeruleus, adult, donor10252	10165-103B3	376.30	2.95	1.85	1.66	0.55	1.66	0.18	0.55	0.37
locus coeruleus, adult, donor10258	10375-105G6	164.20	2.82	0.85	0.85	1.13	1.41	0.28	0.28	1.13
locus coeruleus, newborn, donor10223	10362-105F2	589.71	5.47	4.21	1.26	0.42	0.84	0.00	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	898.74	2.21	1.94	1.11	0.97	0.14	0.28	0.55	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	1173.37	1.38	3.45	0.69	0.69	2.07	4.14	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	1197.68	6.46	5.80	3.56	1.98	0.26	0.79	3.56	2.90
lung, adult, pool1	10019-101D1	909.46	12.17	12.29	7.80	1.42	1.54	0.12	2.60	1.18
lung, fetal, donor1	10068-101I5	2564.96	7.14	8.85	2.00	2.28	2.85	0.00	0.57	0.29
lung, right lower lobe, adult, donor1	10075-102A3	908.18	16.95	20.62	16.95	2.75	0.92	0.00	3.67	3.67
lymph node, adult, donor1	10077-102A5	1292.75	19.41	12.31	22.72	1.89	0.47	0.47	3.79	4.26
lymphangiectasia cell line:DS-1	10727-110A7	1474.63	5.48	5.70	2.85	2.63	0.22	0.22	2.41	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	2253.33	12.23	4.53	2.87	4.38	0.45	1.51	1.96	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	2347.16	11.89	11.04	5.10	0.00	0.85	1.70	0.85	4.25
mature adipocyte, donor1	12231-129F8	259.73	2.66	4.00	3.55	0.00	0.44	0.44	0.00	0.44
mature adipocyte, donor2	12232-129F9	326.03	4.57	3.11	1.25	0.21	0.21	0.00	0.62	0.00
mature adipocyte, donor3	12233-129G1	349.90	6.40	3.08	2.84	0.24	0.47	0.00	1.19	0.00
mature adipocyte, donor4	12234-129G2	301.91	4.21	7.63	2.63	0.53	0.53	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	2906.05	26.69	23.59	12.63	0.48	3.10	2.62	3.57	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	266.22	1.13	0.00	1.13	0.00	2.26	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	476.13	1.84	0.74	2.21	0.37	2.57	1.29	0.18	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	187.44	0.95	0.00	0.32	0.32	1.91	0.95	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	123.68	1.71	1.71	1.28	0.85	0.00	0.00	0.00	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	377.83	1.35	0.84	1.86	1.35	3.21	1.52	1.86	1.01
medial temporal gyrus, adult, donor10252	10156-103A3	475.38	1.49	0.64	2.12	0.42	2.33	1.06	0.42	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	142.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1191.35	14.35	14.35	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	311.19	1.08	1.08	1.44	0.36	1.08	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	362.78	0.00	2.60	0.00	1.30	0.00	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	604.04	4.64	2.01	1.70	0.77	1.08	0.00	0.46	0.93
medulla oblongata, adult, pool1	10038-101F2	426.09	1.88	0.90	1.06	0.24	0.82	0.49	0.16	0.24
medulla oblongata, newborn, donor10223	10361-105F1	220.81	2.08	2.08	1.04	0.69	0.35	0.00	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	5432.56	29.23	14.17	9.30	5.09	0.89	4.21	5.31	5.31
medulloblastoma cell line:ONS-76	10759-110E3	1281.79	4.52	2.32	1.22	0.98	1.47	1.10	1.83	0.73
melanoma cell line:COLO 679	10514-107E1	792.62	7.76	7.33	5.89	1.29	0.00	0.57	1.29	0.29
melanoma cell line:G-361	10465-106H6	1311.16	17.37	26.60	12.22	2.44	0.54	1.09	4.07	0.27
meningioma cell line:HKBMM	10691-109F7	543.80	4.52	2.35	0.54	1.09	0.18	0.18	1.63	1.99
merkel cell carcinoma cell line:MKL-1	10843-111E6	683.78	7.05	1.76	0.00	4.41	1.76	0.88	4.41	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	503.67	2.85	1.56	0.78	0.78	1.56	1.81	1.04	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	494.06	2.15	1.07	0.61	0.46	0.15	0.00	0.15	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	544.80	2.73	1.64	1.45	1.27	0.00	0.00	0.55	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	481.19	1.66	1.24	0.41	0.83	0.00	0.41	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	540.97	1.26	0.84	1.12	1.26	0.00	0.00	0.28	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	437.71	1.54	1.54	0.77	1.16	0.19	0.00	0.19	3.08
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	217.25	1.39	2.78	0.00	1.39	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	529.32	4.46	3.43	3.60	0.69	0.00	0.34	0.34	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	460.41	3.80	3.80	2.76	1.15	0.00	0.23	0.23	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	403.48	2.39	1.19	0.66	1.19	0.40	0.13	0.00	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	321.26	1.08	0.95	0.81	1.22	0.00	0.41	0.27	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	418.54	1.00	1.85	0.85	1.14	0.14	0.14	0.43	1.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	398.19	1.32	1.65	0.66	0.00	0.33	0.33	2.63	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	373.88	0.97	1.66	0.69	1.11	0.14	0.28	0.28	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	289.39	2.09	2.09	1.05	0.35	0.00	0.70	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	380.97	2.45	0.82	0.61	1.43	0.41	0.20	0.41	2.04
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	264.92	1.44	2.16	0.72	1.44	0.36	0.36	1.44	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	363.01	1.76	1.45	0.31	0.41	0.31	0.00	0.21	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	203.14	2.74	0.91	0.23	0.00	0.00	0.23	0.46	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	428.79	3.36	0.42	0.84	0.84	0.42	0.42	0.00	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	339.07	0.90	0.45	0.45	0.60	0.00	0.15	0.00	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	424.26	2.10	0.96	0.26	0.79	0.18	0.18	0.09	0.96
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	381.41	2.21	1.47	1.10	1.84	0.37	0.00	1.10	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	247.53	2.58	1.43	0.86	0.86	0.29	0.57	0.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	415.54	2.53	1.68	0.84	0.84	0.00	0.00	0.42	3.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	363.05	2.28	0.91	3.20	0.91	0.46	0.00	0.91	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	423.07	2.81	2.56	1.53	0.26	0.00	0.26	1.53	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	410.96	3.66	2.09	1.83	2.36	0.52	0.00	1.31	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	404.21	2.46	2.16	0.62	0.62	0.00	0.62	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	406.93	2.82	2.59	1.18	1.41	0.00	0.24	0.47	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	397.69	4.74	2.03	1.35	2.03	0.34	0.00	0.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	380.79	2.75	1.57	0.39	0.00	0.39	0.39	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	376.73	4.17	1.39	2.32	1.85	0.00	0.00	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	627.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	426.28	2.31	1.73	0.87	1.15	0.00	0.00	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	439.28	3.57	2.01	2.01	1.34	0.67	0.00	1.12	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	417.97	2.16	2.16	0.24	0.24	0.00	0.24	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	448.80	0.73	0.00	0.00	0.73	0.00	0.73	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	375.60	3.02	1.68	0.67	2.69	0.00	0.00	1.34	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	392.59	4.50	0.82	0.41	0.41	1.23	0.00	0.41	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	375.00	3.01	1.72	1.29	1.29	0.00	0.00	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	267.97	2.73	0.00	0.00	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	273.74	0.00	0.00	0.00	15.49	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	263.73	3.90	3.90	1.95	0.32	0.00	0.65	0.65	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	272.08	4.36	4.36	0.00	1.45	0.00	0.00	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	278.27	1.07	2.13	1.60	0.53	0.00	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	219.16	2.45	0.82	0.82	2.45	0.82	0.00	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	318.36	4.66	1.94	1.94	1.94	0.39	0.00	2.33	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	193.08	2.10	0.00	0.00	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	256.31	0.99	0.00	0.00	1.99	0.99	0.00	1.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	257.43	0.00	0.00	4.77	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	281.66	1.19	1.78	2.37	0.59	0.59	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	338.73	3.66	2.44	2.44	2.44	0.00	1.22	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	216.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	271.72	1.90	0.63	0.63	3.17	0.00	0.00	1.90	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	356.29	3.45	2.76	0.69	1.72	0.00	0.00	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	279.40	2.15	2.15	2.15	2.15	0.00	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	299.38	0.00	3.99	0.00	3.99	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	378.83	3.44	6.89	0.00	13.78	0.00	0.00	3.44	17.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	321.09	1.22	1.63	1.63	1.22	0.00	0.00	1.22	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	346.38	3.18	0.79	0.00	3.18	0.00	0.00	0.79	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	328.96	2.36	2.95	0.00	2.36	0.00	0.00	2.36	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	387.76	3.12	2.18	0.62	1.25	0.31	0.00	1.25	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	359.57	1.34	2.67	1.34	1.34	0.00	0.00	5.35	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	292.12	5.91	1.18	0.00	3.55	0.00	0.00	3.55	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	377.50	10.27	2.57	5.14	0.00	0.00	0.00	2.57	10.27
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	297.39	0.69	1.38	1.38	0.69	0.00	0.00	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	288.47	2.97	1.98	0.99	1.48	0.00	0.00	0.00	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	223.18	2.24	1.12	1.12	0.00	0.00	1.12	2.24	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	253.15	2.54	0.00	0.00	2.54	0.00	0.00	1.91	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	157.57	2.01	0.40	0.81	0.40	0.00	0.00	0.40	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	213.70	2.18	0.00	0.00	6.54	0.00	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	184.99	0.00	0.00	0.00	2.53	0.00	0.00	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	354.42	2.43	0.61	0.61	1.21	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	275.66	4.52	4.52	0.00	9.04	0.00	0.00	0.00	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	217.45	3.29	1.65	1.65	1.65	0.00	0.00	1.65	4.94
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	197.83	1.19	1.79	1.19	0.00	0.20	0.00	0.20	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	219.36	1.95	1.95	2.60	0.97	0.32	0.00	0.97	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	199.65	2.04	2.04	1.02	2.04	0.00	0.00	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	359.00	0.00	0.77	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	1288.93	4.72	6.38	2.83	2.83	0.94	0.94	2.36	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	661.89	2.78	1.62	0.46	0.23	0.46	0.46	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	931.64	0.00	8.55	0.00	8.55	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	857.66	3.49	2.26	0.92	3.39	1.13	0.21	0.92	6.78
mesothelioma cell line:Mero-25	10850-111F4	621.17	2.50	1.59	1.36	3.40	0.45	0.68	1.59	2.27
mesothelioma cell line:Mero-41	10851-111F5	751.27	3.91	2.93	0.49	2.69	0.00	0.24	0.98	0.98
mesothelioma cell line:Mero-48a	10852-111F6	848.74	4.21	2.44	1.99	2.66	0.66	0.00	1.11	1.77
mesothelioma cell line:Mero-82	10853-111F7	1609.16	8.41	10.25	4.20	7.10	0.53	0.00	3.94	6.57
mesothelioma cell line:Mero-83	10854-111F8	1209.76	8.00	10.38	4.77	6.13	0.51	0.34	1.70	3.23
mesothelioma cell line:Mero-84	10855-111F9	659.74	5.81	1.52	1.01	2.27	0.00	0.00	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	1094.43	8.28	10.56	3.11	3.52	0.21	1.24	2.48	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	1921.84	11.60	11.10	4.97	6.29	0.50	0.17	3.98	1.99
mesothelioma cell line:NCI-H226	10846-111E9	899.53	4.34	3.98	1.27	3.62	0.00	0.18	2.17	3.26
mesothelioma cell line:NCI-H2452	10848-111F2	579.26	2.56	2.22	1.71	2.73	0.34	0.34	0.68	0.34
mesothelioma cell line:NCI-H28	10845-111E8	594.18	2.54	2.54	0.00	2.04	0.25	0.25	1.27	1.02
mesothelioma cell line:No36	10857-111G2	451.79	1.30	3.26	0.33	1.96	0.98	0.33	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	343.03	1.63	1.08	1.08	2.71	0.00	0.00	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	1078.41	8.25	12.67	2.49	3.65	0.00	0.00	0.58	0.96
migratory langerhans cells, donor2	11902-125F3	844.92	4.40	5.37	1.22	2.08	0.24	0.12	0.37	0.24
migratory langerhans cells, donor3	11903-125F4	1102.01	7.36	4.85	2.87	1.44	0.00	0.18	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	625.53	5.55	6.53	0.98	6.86	0.33	0.65	5.22	6.53
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	363.89	2.33	1.70	0.42	0.64	0.64	0.00	0.64	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	1990.29	2.99	4.61	1.15	1.61	0.46	1.61	1.61	1.61
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	1151.84	7.80	8.18	1.71	1.33	0.19	0.19	1.90	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	3176.95	12.20	5.91	4.99	4.07	1.29	1.11	3.14	2.40
myeloma cell line:PCM6	10474-106I6	764.97	3.56	3.16	3.16	2.17	0.40	0.20	1.19	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	620.92	1.01	1.52	1.01	1.01	1.01	0.51	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	909.89	5.10	4.12	2.16	1.37	0.59	1.18	2.16	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	724.15	3.12	1.56	0.89	1.89	0.00	0.11	1.00	1.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	489.41	3.02	2.06	1.25	0.74	0.07	0.15	0.22	1.03
nasal epithelial cells, donor2	12227-129F4	1370.59	4.42	1.10	2.76	1.10	0.55	0.00	2.21	0.00
neuroblastoma cell line:CHP-134	10508-107D4	2015.79	6.44	2.53	2.07	0.23	0.69	0.92	1.15	0.00
neuroblastoma cell line:NB-1	10539-107G8	825.42	2.43	0.94	2.25	1.31	1.31	0.19	0.56	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	581.63	2.74	1.90	0.42	1.27	0.21	1.05	1.05	1.90
neuroblastoma cell line:NH-12	10555-107I6	1361.29	3.73	2.80	1.68	1.49	0.56	0.75	1.30	2.61
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	1083.41	7.12	1.90	2.14	0.47	0.00	0.24	2.14	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1232.68	13.62	10.14	9.03	3.96	0.32	0.16	2.38	1.90
neuroectodermal tumor cell line:TASK1	10774-110F9	889.77	2.42	1.81	1.21	1.41	0.20	0.20	1.21	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	1155.19	3.18	1.27	0.00	1.91	0.00	1.27	4.45	2.54
neurofibroma cell line:Hs 53.T	10729-110A9	702.41	1.86	1.06	0.27	0.80	0.80	0.00	0.53	0.27
neutrophil PMN, donor1	12133-128D9	163.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	0.00	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1848.15	9.30	4.40	5.07	1.01	1.18	0.68	2.37	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	369.83	1.60	1.60	5.60	0.80	0.80	0.00	0.80	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	546.63	3.53	1.28	1.92	1.60	0.32	0.00	1.28	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	306.91	3.68	1.31	0.53	0.26	0.00	0.00	0.00	1.58
nucleus accumbens, adult, pool1	10037-101F1	410.95	1.12	0.37	1.50	0.19	1.87	0.47	0.19	0.19
occipital cortex - adult, donor10196	10172-103C1	426.50	2.06	0.00	8.24	0.00	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	538.07	1.88	1.34	0.27	0.00	3.22	0.81	0.81	0.27
occipital cortex, newborn, donor10223	10355-105E4	273.32	0.73	0.36	1.82	0.73	1.46	0.00	2.18	0.36
occipital lobe, adult, donor1	10076-102A4	276.83	3.94	2.10	2.36	1.05	1.84	1.05	0.26	0.26
occipital lobe, fetal, donor1	10073-102A1	1269.71	12.44	8.58	3.00	2.15	1.29	0.00	0.86	0.86
occipital pole, adult, pool1	10036-101E9	263.09	0.95	0.71	0.79	0.08	1.42	0.79	0.16	0.16
olfactory region, adult	10195-103E6	273.97	2.10	0.96	0.00	0.00	2.67	0.38	0.19	0.38
optic nerve, donor1	10277-104E7	220.12	0.00	10.01	2.00	0.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	2292.17	22.78	24.15	15.38	1.71	0.80	2.05	3.19	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1966.82	4.81	3.57	2.06	1.10	0.69	0.41	1.10	0.96
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	946.86	7.11	4.74	2.20	2.03	0.51	0.00	1.69	2.03
oral squamous cell carcinoma cell line:SAS	10544-107H4	3293.50	16.06	12.82	7.28	4.97	0.69	0.46	6.01	9.13
osteoclastoma cell line:Hs 706.T	10704-109H2	494.45	4.41	4.41	2.94	0.59	0.29	0.59	1.47	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	1751.88	1.87	2.80	1.87	1.87	4.67	0.00	3.74	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	5678.30	20.78	19.93	12.94	6.36	1.70	1.06	3.82	2.54
ovary, adult, pool1	10020-101D2	980.35	10.05	10.48	9.43	0.70	1.05	0.17	1.22	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	1258.68	3.67	2.93	2.93	2.20	0.73	0.92	4.95	2.93
pancreas, adult, donor1	10049-101G4	751.57	5.64	2.82	2.82	0.00	0.94	0.94	1.88	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1756.04	12.58	16.77	6.99	1.96	0.28	0.84	2.52	1.96
papillary adenocarcinoma cell line:8505C	10437-106E5	1097.76	8.01	2.21	1.36	4.09	0.51	1.19	2.04	4.43
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	1125.46	9.11	8.61	3.15	0.66	0.17	0.33	0.99	0.66
paracentral gyrus, adult, pool1	10035-101E8	267.15	1.19	0.64	1.92	0.27	1.46	0.55	0.09	0.09
parietal cortex, adult, donor10258	10373-105G4	563.72	0.73	0.00	0.73	0.00	1.47	0.73	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	247.35	2.82	0.00	0.00	0.00	0.94	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	475.16	1.71	0.29	1.14	0.57	1.14	0.29	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	314.85	0.70	0.44	0.88	0.53	1.32	1.23	0.18	0.35
parietal lobe, fetal, donor1	10072-101I9	1375.22	8.73	10.67	3.88	1.94	3.88	0.00	0.97	3.88
parietal lobe, newborn, donor10223	10356-105E5	326.75	2.24	1.87	1.12	0.37	1.87	0.00	0.75	1.50
parotid gland, adult	10199-103F1	2634.39	27.13	25.28	9.87	2.47	1.23	0.00	1.23	1.85
penis, adult	10200-103F2	421.63	3.76	2.69	6.45	0.54	1.07	0.00	2.69	5.91
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	1693.69	7.25	5.21	5.39	2.79	0.00	0.93	1.86	2.05
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	1537.37	6.26	7.43	2.91	2.91	0.44	0.87	2.33	3.35
pineal gland - adult, donor10196	10179-103C8	314.13	0.65	2.58	0.65	0.00	1.29	0.65	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	700.59	1.18	1.18	1.78	1.18	4.74	0.59	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	206.31	0.00	3.14	2.51	0.63	1.88	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	537.27	3.04	1.01	1.01	1.01	1.01	0.00	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	756.23	2.08	2.61	4.17	0.52	3.65	1.04	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	342.20	1.70	1.70	2.55	0.85	3.40	0.85	1.70	0.00
placenta, adult, pool1	10021-101D3	514.51	3.66	2.04	2.58	0.32	0.32	0.00	0.11	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	1451.40	7.15	2.91	3.44	3.31	0.40	0.26	3.18	1.19
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	419.76	2.33	1.40	1.25	0.47	0.31	0.00	0.62	0.00
pons, adult, pool1	10033-101E6	307.60	1.12	0.77	0.77	0.43	0.52	0.77	0.17	0.00
postcentral gyrus, adult, pool1	10032-101E5	249.76	0.78	0.52	1.48	0.17	1.22	0.26	0.17	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	18.82	0.00	0.00	0.00	0.00	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	352.51	0.00	0.00	0.00	5.51	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	269.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	740.84	2.33	1.75	0.58	2.33	1.31	0.58	2.18	0.15
prostate cancer cell line:PC-3	10439-106E7	1901.05	3.27	3.45	2.00	2.72	2.00	1.45	3.81	3.99
prostate, adult, pool1	10022-101D4	981.47	8.43	9.25	6.26	0.91	1.54	0.09	1.18	0.91
putamen, adult, donor10196	10176-103C5	548.38	3.30	0.71	0.47	0.00	2.12	1.89	0.24	0.71
putamen, adult, donor10252	10152-102I8	201.95	1.96	0.00	0.00	1.96	0.00	1.96	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	439.31	0.00	0.00	0.00	0.00	1.09	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	272.30	0.97	1.45	0.24	0.24	0.72	1.69	0.97	0.48
putamen, newborn, donor10223	10365-105F5	830.62	3.75	5.25	2.25	0.75	0.75	0.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	2491.28	9.89	8.73	2.33	2.91	2.04	2.04	4.65	1.16
rectum, fetal, donor1	10067-101I4	600.91	4.17	1.39	2.78	4.17	0.00	0.00	2.78	5.56
renal cell carcinoma cell line:OS-RC-2	10411-106B6	237.86	1.70	1.27	0.21	0.21	0.00	0.00	0.42	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	438.65	0.41	0.41	0.41	0.83	2.49	0.41	1.24	0.83
retina, adult, pool1	10030-101E3	612.70	3.18	1.99	1.89	0.50	0.50	0.00	0.10	0.60
retinoblastoma cell line:Y79	10475-106I7	1922.02	3.90	3.90	2.08	2.34	1.82	1.04	3.12	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	620.15	1.60	0.98	0.49	0.37	0.86	0.25	1.11	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	3577.15	7.31	4.78	0.84	2.53	2.53	0.28	5.62	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	610.83	2.27	1.52	1.52	1.52	0.00	0.76	3.03	1.52
salivary acinar cells, donor1	11771-123I7	1275.43	12.79	11.01	5.34	1.94	0.32	0.00	2.59	1.78
salivary acinar cells, donor2	11772-123I8	974.14	16.66	9.50	4.68	2.34	0.28	0.14	2.48	2.89
salivary acinar cells, donor3	11773-123I9	882.51	2.65	2.65	0.66	1.32	2.65	1.32	4.63	1.32
salivary gland, adult, pool1	10093-102C3	2630.98	9.72	4.00	1.14	2.29	0.57	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	721.71	3.20	5.06	3.46	1.52	0.84	1.26	0.93	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	673.92	2.23	4.47	1.65	0.71	0.35	1.41	0.59	0.24
seminal vesicle, adult	10201-103F3	879.32	8.47	16.93	5.29	6.35	1.59	0.00	2.65	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	693.31	4.62	3.16	0.97	0.97	0.24	0.00	0.24	2.19
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	365.12	3.77	2.01	1.26	2.01	1.01	0.00	0.75	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	266.94	1.00	0.00	0.00	2.01	1.00	0.00	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	657.23	3.36	0.67	1.21	1.61	0.13	0.40	0.81	1.88
signet ring carcinoma cell line:Kato III	10436-106E4	937.83	4.86	6.63	2.87	1.22	0.22	0.33	1.22	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	799.96	3.74	3.74	2.19	1.55	0.39	0.39	1.03	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	117.75	0.00	0.71	0.00	0.00	0.71	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	371.69	3.72	3.12	3.36	0.12	0.36	0.12	0.24	0.24
skeletal muscle, fetal, donor1	10066-101I3	449.24	3.02	5.03	5.03	1.01	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	916.00	6.79	6.79	13.57	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	742.32	6.94	7.57	4.42	1.89	0.63	0.00	1.26	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	580.00	2.67	1.33	1.00	1.00	0.00	0.67	1.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1803.29	10.72	5.36	2.84	5.04	3.15	0.95	0.32	4.10
small cell lung carcinoma cell line:DMS 144	10841-111E4	871.22	7.90	3.47	2.51	2.12	3.66	0.58	1.73	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	2581.52	6.10	9.23	3.79	1.98	0.82	0.66	1.81	1.65
small cell lung carcinoma cell line:NCI-H82	10842-111E5	2153.78	12.71	6.43	3.70	3.38	3.86	1.45	3.22	1.93
small cell lung carcinoma cell line:WA-hT	10562-108A4	1069.32	1.74	2.83	0.65	2.62	0.87	1.96	1.53	2.40
small intestine, adult, pool1	10024-101D6	1395.33	18.16	16.24	13.74	1.43	0.60	0.24	2.51	0.84
small intestine, fetal, donor1	10064-101I1	1226.02	5.41	6.14	2.70	2.46	0.49	0.00	0.74	2.21
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	507.77	2.05	3.08	1.54	5.13	0.00	0.51	0.51	1.54
smooth muscle, adult, pool1	10048-101G3	846.70	4.14	2.84	2.84	1.81	1.03	0.26	0.78	2.84
somatostatinoma cell line:QGP-1	10781-110G7	590.99	0.80	2.14	1.07	0.27	0.00	0.00	0.80	0.80
spinal cord - adult, donor10196	10181-103D1	708.41	2.75	2.06	2.06	0.69	1.38	0.23	1.38	0.92
spinal cord, adult, donor10252	10159-103A6	1012.49	1.97	4.34	3.55	1.18	2.37	0.79	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	433.76	0.00	0.69	0.00	0.69	0.69	0.00	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	497.02	3.05	1.22	1.22	1.83	0.61	0.00	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	143.27	1.84	1.84	0.00	0.00	0.00	0.46	0.00	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	534.39	1.64	1.94	0.45	0.90	0.15	0.60	1.94	1.19
spleen, adult, pool1	10025-101D7	1406.63	13.44	13.11	7.71	0.99	0.66	0.00	1.76	0.99
spleen, fetal, pool1	10044-101F8	1100.37	5.48	4.85	3.10	0.79	0.48	0.16	0.87	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	1321.44	7.45	2.79	1.04	1.04	0.83	0.52	0.93	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	1020.01	2.85	4.18	1.71	0.95	0.95	0.57	3.04	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	3800.64	24.46	15.03	7.34	15.38	7.34	2.45	10.13	9.78
squamous cell carcinoma cell line:T3M-5	10616-108G4	1359.66	7.04	8.60	1.95	1.17	0.00	0.39	2.74	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	1555.00	4.16	2.59	0.90	1.69	0.23	0.56	1.80	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	1003.94	5.93	2.97	2.12	5.51	2.12	0.42	2.54	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	779.72	6.35	2.12	1.27	1.27	2.96	1.27	0.42	0.00
stomach, fetal, donor1	10062-101H8	696.32	1.07	3.20	2.14	0.00	0.00	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	1609.35	24.50	12.53	8.55	6.27	1.14	0.57	1.71	6.84
substantia nigra - adult, donor10196	10178-103C7	542.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	557.69	2.08	1.66	1.87	0.62	1.66	0.83	0.00	0.21
substantia nigra, adult, donor10258	10371-105G2	203.80	0.00	0.00	0.52	0.00	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	322.20	1.41	2.83	2.12	1.41	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	1317.13	5.27	4.81	3.21	2.06	1.38	1.15	3.44	2.75
temporal lobe, adult, pool1	10031-101E4	243.12	0.76	1.02	1.27	0.25	2.20	0.59	0.08	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	1374.68	11.40	3.56	7.83	3.56	0.00	1.42	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	816.66	5.71	5.27	1.76	0.88	1.76	0.44	1.76	0.88
tenocyte, donor1	11763-123H8	525.40	2.44	1.40	1.05	2.44	0.00	0.00	4.19	0.70
tenocyte, donor2	11765-123I1	492.14	1.91	1.53	2.29	1.53	0.76	0.00	3.05	2.29
tenocyte, donor3	11768-123I4	637.91	2.22	0.37	0.74	1.85	0.74	0.00	3.71	5.93
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	1632.81	5.95	2.55	1.02	2.89	1.53	0.51	1.36	1.87
teratocarcinoma cell line:NCR-G1	10798-110I6	636.63	3.24	3.70	2.31	1.23	0.46	0.77	0.92	0.77
teratocarcinoma cell line:PA-1	10807-111A6	1867.95	8.83	5.11	3.25	4.03	0.62	1.39	2.79	1.55
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	2605.22	39.10	31.99	18.79	2.03	1.90	2.29	7.36	1.78
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	1490.38	4.54	4.92	1.89	1.89	3.40	0.00	1.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	3429.36	22.58	19.74	13.96	2.07	1.53	0.33	3.16	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2179.60	17.26	12.38	5.21	6.51	1.30	0.65	3.58	12.05
testis, adult, pool1	10026-101D8	854.15	17.61	28.67	33.29	3.11	172.98	200.68	3.22	1.40
testis, adult, pool2	10096-102C6	1013.14	11.28	12.63	16.24	4.51	292.30	439.36	1.80	4.06
thalamus - adult, donor10196	10168-103B6	379.77	2.21	1.10	1.10	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	547.77	3.91	1.25	1.72	0.47	2.34	0.63	0.78	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	130.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	142.13	2.14	1.48	1.65	0.66	0.99	0.33	0.99	1.65
thalamus, newborn, donor10223	10366-105F6	233.00	2.30	1.73	2.30	0.58	0.00	0.00	0.00	0.00
throat, adult	10209-103G2	580.48	9.24	7.49	4.49	0.75	0.75	0.00	1.00	0.00
throat, fetal, donor1	10061-101H7	713.32	6.40	1.83	1.52	0.61	0.91	0.00	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	1074.94	3.58	2.38	0.79	3.78	0.00	0.79	0.79	0.00
thymus, adult, pool1	10027-101D9	1577.32	21.08	19.19	12.82	1.19	0.30	0.20	3.28	1.19
thymus, fetal, pool1	10043-101F7	1767.21	12.05	11.22	6.75	1.35	1.14	0.10	2.08	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	1982.84	8.91	6.91	3.99	4.39	1.20	0.40	1.46	2.79
thyroid carcinoma cell line:TCO-1	10783-110G9	1818.63	6.57	5.73	2.37	2.51	0.42	0.42	2.65	1.96
thyroid, adult, pool1	10028-101E1	808.46	6.35	6.53	4.85	0.47	0.28	0.19	0.93	0.65
thyroid, fetal, donor1	10060-101H6	481.45	3.69	1.05	2.11	1.05	0.53	0.26	1.05	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	671.36	3.08	9.24	0.00	0.00	0.00	0.00	3.08	3.08
tongue, adult	10203-103F5	582.61	8.84	13.02	4.65	1.63	0.93	0.47	1.16	1.63
tongue, fetal, donor1	10059-101H5	712.52	4.34	3.15	2.76	0.79	0.79	0.00	0.79	1.97
tonsil, adult, pool1	10047-101G2	2119.32	9.72	7.21	3.31	1.30	0.70	0.70	1.80	0.70
trachea, adult, pool1	10029-101E2	1153.93	9.16	9.90	6.63	1.15	0.33	0.16	1.31	0.65
trachea, fetal, donor1	10058-101H4	687.83	3.85	6.54	5.00	0.00	0.00	0.00	0.38	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	728.74	2.83	0.71	0.00	0.71	0.35	0.35	1.06	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	1285.10	6.08	4.66	2.03	0.61	0.91	0.71	0.91	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	3081.25	27.42	31.34	15.51	5.48	0.78	0.78	4.23	2.19
tridermal teratoma cell line:HGRT	10694-109G1	456.61	0.00	3.81	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	1507.96	8.80	9.82	3.89	1.19	0.42	0.34	1.19	1.61
umbilical cord, fetal, donor1	10057-101H3	1080.81	0.00	0.00	0.00	0.00	2.09	2.09	0.00	4.17
uterus, adult, pool1	10100-102D1	1206.51	5.12	4.27	1.19	0.51	1.02	0.00	0.85	0.17
uterus, fetal, donor1	10055-101H1	1086.31	4.10	5.63	1.54	2.05	0.00	0.00	0.00	6.14
vagina, adult	10204-103F6	659.77	6.46	7.11	3.23	0.00	0.00	0.00	0.65	0.65
vein, adult	10191-103E2	804.90	8.33	14.47	8.77	1.10	1.10	0.22	1.32	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	990.17	4.01	1.60	1.34	2.40	0.53	0.00	1.34	1.87